<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4503854E-4E22-4985-86CB-6C8B685C15FF"><gtr:id>4503854E-4E22-4985-86CB-6C8B685C15FF</gtr:id><gtr:name>PRISMA ONG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FCADB4C3-A4F5-41CC-ADE0-3845BCB6A916"><gtr:id>FCADB4C3-A4F5-41CC-ADE0-3845BCB6A916</gtr:id><gtr:name>Peruvian University Cayetano Heredia</gtr:name><gtr:address><gtr:line1>Av Honorio Delgado 340</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4AE560B0-AF35-412B-96F1-389CAA52AE8F"><gtr:id>4AE560B0-AF35-412B-96F1-389CAA52AE8F</gtr:id><gtr:name>United Nations (UN)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0FA4F51E-8CA8-4738-B531-34902F6C802D"><gtr:id>0FA4F51E-8CA8-4738-B531-34902F6C802D</gtr:id><gtr:name>Peruvian Association of Persons Affected by Tuberculosis (ASPAT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BF3CF058-25CA-49FF-BC76-75092B6E5658"><gtr:id>BF3CF058-25CA-49FF-BC76-75092B6E5658</gtr:id><gtr:name>World Bank Group</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/814D0949-3E43-4D4E-A3D3-8B0654B51D78"><gtr:id>814D0949-3E43-4D4E-A3D3-8B0654B51D78</gtr:id><gtr:name>Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/77E79B8B-5CEA-493F-93F7-388B834AC43F"><gtr:id>77E79B8B-5CEA-493F-93F7-388B834AC43F</gtr:id><gtr:name>Municipality of Lima</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1352CE29-1B59-4D13-BDE7-8EBFFFD05731"><gtr:id>1352CE29-1B59-4D13-BDE7-8EBFFFD05731</gtr:id><gtr:name>Callao Regional Directorate of Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C642E258-6416-4B03-8E30-416004335B87"><gtr:id>C642E258-6416-4B03-8E30-416004335B87</gtr:id><gtr:name>GENETUP</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/24A0945C-470C-4693-9C25-67BCB176D683"><gtr:id>24A0945C-470C-4693-9C25-67BCB176D683</gtr:id><gtr:name>National TB Reference Laboratory, Tbilisi, Georgia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DEAE3701-4328-4504-92F6-71375099B7DB"><gtr:id>DEAE3701-4328-4504-92F6-71375099B7DB</gtr:id><gtr:name>Naval Medical Research Center Unit-6</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/876092E2-F5CA-4E78-9D72-B18484B90964"><gtr:id>876092E2-F5CA-4E78-9D72-B18484B90964</gtr:id><gtr:name>United States Air Force (USAF)</gtr:name><gtr:address><gtr:line1>Headquarters</gtr:line1><gtr:line2>1000 Air Force Pentagon</gtr:line2><gtr:line3>Washington</gtr:line3><gtr:line5>DC 20330-1000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0826E38F-C9A8-4C12-A798-6DE8B989FDF9"><gtr:id>0826E38F-C9A8-4C12-A798-6DE8B989FDF9</gtr:id><gtr:name>Regional Government of Callao (Gobierno Regional de Callao)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4503854E-4E22-4985-86CB-6C8B685C15FF"><gtr:id>4503854E-4E22-4985-86CB-6C8B685C15FF</gtr:id><gtr:name>PRISMA ONG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FCADB4C3-A4F5-41CC-ADE0-3845BCB6A916"><gtr:id>FCADB4C3-A4F5-41CC-ADE0-3845BCB6A916</gtr:id><gtr:name>Peruvian University Cayetano Heredia</gtr:name><gtr:address><gtr:line1>Av Honorio Delgado 340</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4AE560B0-AF35-412B-96F1-389CAA52AE8F"><gtr:id>4AE560B0-AF35-412B-96F1-389CAA52AE8F</gtr:id><gtr:name>United Nations (UN)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0FA4F51E-8CA8-4738-B531-34902F6C802D"><gtr:id>0FA4F51E-8CA8-4738-B531-34902F6C802D</gtr:id><gtr:name>Peruvian Association of Persons Affected by Tuberculosis (ASPAT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BF3CF058-25CA-49FF-BC76-75092B6E5658"><gtr:id>BF3CF058-25CA-49FF-BC76-75092B6E5658</gtr:id><gtr:name>World Bank Group</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/814D0949-3E43-4D4E-A3D3-8B0654B51D78"><gtr:id>814D0949-3E43-4D4E-A3D3-8B0654B51D78</gtr:id><gtr:name>Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/77E79B8B-5CEA-493F-93F7-388B834AC43F"><gtr:id>77E79B8B-5CEA-493F-93F7-388B834AC43F</gtr:id><gtr:name>Municipality of Lima</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1352CE29-1B59-4D13-BDE7-8EBFFFD05731"><gtr:id>1352CE29-1B59-4D13-BDE7-8EBFFFD05731</gtr:id><gtr:name>Callao Regional Directorate of Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C642E258-6416-4B03-8E30-416004335B87"><gtr:id>C642E258-6416-4B03-8E30-416004335B87</gtr:id><gtr:name>GENETUP</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/24A0945C-470C-4693-9C25-67BCB176D683"><gtr:id>24A0945C-470C-4693-9C25-67BCB176D683</gtr:id><gtr:name>National TB Reference Laboratory, Tbilisi, Georgia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DEAE3701-4328-4504-92F6-71375099B7DB"><gtr:id>DEAE3701-4328-4504-92F6-71375099B7DB</gtr:id><gtr:name>Naval Medical Research Center Unit-6</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/876092E2-F5CA-4E78-9D72-B18484B90964"><gtr:id>876092E2-F5CA-4E78-9D72-B18484B90964</gtr:id><gtr:name>United States Air Force (USAF)</gtr:name><gtr:address><gtr:line1>Headquarters</gtr:line1><gtr:line2>1000 Air Force Pentagon</gtr:line2><gtr:line3>Washington</gtr:line3><gtr:line5>DC 20330-1000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0826E38F-C9A8-4C12-A798-6DE8B989FDF9"><gtr:id>0826E38F-C9A8-4C12-A798-6DE8B989FDF9</gtr:id><gtr:name>Regional Government of Callao (Gobierno Regional de Callao)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9FB96E0B-B7E9-4BCD-B01F-FB7008EEE23D"><gtr:id>9FB96E0B-B7E9-4BCD-B01F-FB7008EEE23D</gtr:id><gtr:firstName>Carlton</gtr:firstName><gtr:otherNames>Anthony</gtr:otherNames><gtr:surname>Evans</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E3A0BD1B-7032-4C00-82E8-6BB5DB101D89"><gtr:id>E3A0BD1B-7032-4C00-82E8-6BB5DB101D89</gtr:id><gtr:firstName>Delia</gtr:firstName><gtr:surname>Boccia</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1651B60E-9CD2-4850-9ADD-364B06B854EB"><gtr:id>1651B60E-9CD2-4850-9ADD-364B06B854EB</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Gilman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/35A062C8-FD19-4B22-83DA-FD21981B5967"><gtr:id>35A062C8-FD19-4B22-83DA-FD21981B5967</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Lewis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/63BD5C7B-D53B-403A-B887-629DB22F2412"><gtr:id>63BD5C7B-D53B-403A-B887-629DB22F2412</gtr:id><gtr:firstName>Marco</gtr:firstName><gtr:otherNames>Antonio</gtr:otherNames><gtr:surname>Tovar</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FK007467%2F1"><gtr:id>30F73E15-ED67-47BA-9623-CB9F0CBC79E9</gtr:id><gtr:title>Community randomised evaluation of socioeconomic intervention to prevent TB</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K007467/1</gtr:grantReference><gtr:abstractText>BACKGROUND. TB kills 1.5 million people each year, more than any other single infection. There is an urgent need to evaluate the impact of new interventions to strengthen TB control. Poverty is increasing globally in cities and urban areas, and is associated with factors that increase TB risk including crowding and malnutrition. Conversely, TB worsens poverty by increasing expenses and reducing income. In addition, those with TB and their families may experience stigma. Poor people have more TB and greater TB-related needs but they tend to have least access to TB care. This mismatch between need for and access to TB care undermines TB control and worsens poverty.

OBJECTIVE. We will evaluate the impact of socioeconomic interventions for reducing poverty, improving access to TB care and consequently reducing the risk of future TB.

SETTING. 24 peri-urban shantytowns in Northern Lima, Peru near the site of our TB control research since 2001. Peru has an acclaimed TB control programme but its levels of TB disease remain high and its rates of multidrug-resistant TB (MDR-TB) have doubled over the last decade to the highest levels in the Americas. The high TB and increasing MDR-TB rates are concentrated in &amp;quot;hotspots&amp;quot; such as poor peri-urban shantytowns surrounding Lima. It is these &amp;quot;hotspots&amp;quot; where we will work.

RELATED WORK. Since 2007, our on going pilot project has been &amp;quot;Innovative Socio-economic Interventions Against TB (ISIAT)&amp;quot; which involves developing and implementing socioeconomic interventions to fight poverty and increase equitable access to TB care. Early analysis of the pilot ISIAT project showed promising results with the interventions described below increasing the number of people to a) complete TB treatment b) complete preventive therapy to prevent them getting TB c) be tested for TB and d) be tested for HIV. These results were published in 2011. The improvement in awareness, prevention and treatment of TB that our work and subsequent article showed has attracted the attention of funding bodies, like the World Bank and The Bill and Melinda Gates Foundation, and policymakers such as the World Health Organisation (WHO) and its Stop-TB department. Our on going relationship and involvement of these organizations and the published results of the pilot ISIAT project are encouraging for future work. The proposed project will rigorously assess the impact of these interventions not just on poverty and access to TB care but also on actual TB control.

INTERVENTIONS AND STUDY DESIGN. The interventions will be inexpensive, involving a team of experts from different fields working with all TB-affected families. They will utilize household visit and fortnightly community meetings to implement an integrated program of social support for enhancing equitable access to TB-related healthcare and economic support to help people to afford TB care and to help them to become less poor.

We will include in the study all members of a household with a new diagnosis of TB, as assessed by the Peruvian national TB program, without age limit, who provides informed written consent.

TB-affected households in 12 intervention communities will be offered the socioeconomic intervention for 6-months whilst the TB patient is receiving TB treatment. TB-affected households in 12 other control communities will be offered no intervention (standard of TB care). We will then re-visit those households 2 years after recruitment to assess what happened to the people with TB and those people in the household exposed to TB, and if our interventions prevented TB and reduced poverty.

BENEFITS: These socio-economic 'structural' interventions will be assessed for their capacity to reduce poverty-related TB risk factors, improve access to TB care and for reducing TB treatment failure, recurrence and transmission. This has potential importance for focusing poverty reduction on those in greatest need and who have the most to benefit and preventing TB.</gtr:abstractText><gtr:technicalSummary>BACKGROUND: TB kills more people than any other single infection. New interventions are needed to strengthen TB control. Poverty hampers access to care, increases vulnerability and is the main determinant of global TB rates. Socioeconomic interventions for TB control have been proposed but there is little evidence to guide how they should be used. 

PRELIMINARY DATA: Socioeconomic intervention increased equitable access to TB care in our published 4-year pilot study.

HYPOTHESIS: Socioeconomic intervention prevents TB by synergistically improving access to TB care and reducing TB vulnerability.

POPULATION: impoverished shantytown households in which one resident has recently been diagnosed as having TB disease, putting the other residents at high risk of TB disease. 

PROPOSAL: A community randomised-controlled study will include 12,552 members of 1,874 households in periurban Lima shantytowns with a registered population of 307,623. The impact of a complex socioeconomic intervention will be assessed by comparing 12 intervention versus 12 control shantytowns. The integrated community-based intervention was developed in our pilot study and includes a social dimension (community mobilisation for health promotion to inform care) and an economic dimension (conditional cash transfers to incentivise and enable care and reduce poverty-related TB vulnerability). 

OUTCOMES: The primary outcome will be the impact of the social and economic interventions preventing TB disease assessed by combining incident TB post-intervention with a final prevalence survey of all participants. Secondary outcomes will be the impact of the interventions increasing equitable access to TB care, reducing poverty and associated TB vulnerability and reduction in community TB rates.

CONCLUSION: This study will provide the first evidence assessing the potential of socioeconomic intervention to prevent TB and its potential to expand TB care into community TB control.</gtr:technicalSummary><gtr:potentialImpactText>WHICH GROUPS WILL BE IMPACTED?
TB-affected families: This project will have a direct impact on the life of TB patients and their families. By reducing TB dissemination it should also have an indirect impact on the life of other people living in the marginalised, poor communities where TB is most common.

TB &amp;amp; poverty stakeholders: Knowledge generated will benefit policy makers, TB control programs, funding providers, NGOs, charities and institutions working in TB prevention, care and human development. 

The project is responding to the World Health Assembly and WHO's recent call for a more integrated approach to the control of diseases disproportionately affecting developing countries. In particular, it responds to the WHO STOP-TB Department increasing interest in innovative interventions to support the current TB control strategy (which is based on case finding and treatment) (Lonnroth K, 2009).

The project will contribute to the generation of better disaggregated data on the TB burden in a peri-urban population, whose paucity represents the first challenge in the prevention of TB in informal settlements like the trial setting (David A, 2008).

The project will also benefit NGOs, charities and institutions working in human development by identifying new routes and partners to widen and enhance the impact of their activities.

HOW WILL THE PROJECT IMPACT THESE GROUPS?
TB-affected families: The project results are intended to benefit the people living with a recent TB-diagnosis in the following ways:

1. In the short term, by directly reducing poverty, improving access and use of TB care, increasing empowerment and consequently improving participants' health.

2. In the medium term, by strengthening the coordinated response of civil society and the State to tackle poverty as a means for TB control, influencing regional and national policy.

3. In the long term by influencing knowledge, understanding, policy and practice nationally and globally, this project will benefit TB-affected families in poor communities on a much greater scale. 

TB &amp;amp; poverty stakeholders: The results have the potential to inform policy changes in TB control. TB and poverty stakeholders will be provided with preliminary evidence on the introduction of socioeconomic interventions as an integral part of TB control. This project has the capacity to inspire pragmatic actions for TB control in Peru in the short term. In the medium-longer term, we expect further increased interest from the international donors on this under-researched area, which will lead to the replication and adaptation of the project to other settings. The process evaluation will help understanding of the discrepancies between expected and observed results whilst providing insights into the role of contextual factors and project transferability. 

WHAT WILL BE DONE TO ENSURE THIS IMPACT OCCURS?
TB-affected families: The project team will continue their current day-to-day interventional activities to ensure continuing impact for the project participants. The dissemination activities described in this document will ensure that the TB-affected families in other parts of Peru and other countries will similarly benefit in the medium to long term.

TB &amp;amp; poverty stakeholders: The earlier the engagement with policy makers in the evaluation is, the better will be the outcome (Whitehead M, 2004). Engagement of policy makers is on going with field site visits from WHO, The Bill &amp;amp; Melinda Gates Foundation/FIND and World Bank economists are heavily involved in the project. This early and regular engagement with stakeholders beyond the academic research community is essential for achieving global impact. Throughout the project this will increase interest in the importance of addressing social determinants of health, aims to inspire similar projects in different settings, and will guide the translation of project findings into policy and public health impact.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3168125</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>This booklet describes CRESIPT in layman's terms, provides information on prevention and detection of TB, gives access to other social programs and information on TB discrimination laws in one place. The format is accessible for those of all reading levels. It also gives CRESIPT families a sense of identity and belonging in the mini-society we have formed with our intervention, reducing negative feelings associated with TB stigma.</gtr:description><gtr:id>9229734C-F83E-40B8-BE35-E1257CA8D350</gtr:id><gtr:impact>Patients are better able to understand CRESIPT, have easy access to information about TB, and have a physical representation of belonging to a group.</gtr:impact><gtr:title>Informational Booklet for CRESIPT Families</gtr:title><gtr:type>Artefact (including digital)</gtr:type><gtr:url>https://www.canva.com/design/DACF3JW4J94/5dLbIGa3lO_ugeTSiQFrnQ/edit</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Booklets containing a series of hand-drawn colored pictures depicting culture-specific, locally-relevant events, situations, or encounters in which people with TB may experience enacted, anticipated, and TB self- stigma are used in TB Clubs by people with TB and their family members to facilitate identification of emotions, thoughts, and behaviors associated with these three stigma types.
 Each TB club member is provided a booklet and asked to think about an event, situation, or encounter in which they personally experienced TB stigma. The drawings serve as examples and memory prompts. Club members then describe their experience of TB stigma -- the emotions, associated thoughts, and resultant behaviors. Beyond building supportive networks among club members, identifying and sharing these particular components of their experiences provides the foundation steps for employing cognitive behavior therapy techniques to then explore alternative thoughts and behaviors that serve to empower club members in achieving goals, e.g. adhering to and completing TB treatment, having family members tested for TB.</gtr:description><gtr:id>7E248692-DE31-4443-8767-FD81B17F9F75</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in the delivery phase.</gtr:impact><gtr:title>TB Stigma Drawings Booklet</gtr:title><gtr:type>Artwork</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Collaborators in the World Bank are preparing a video documentary showcasing success stories in empowerment in Peru. They have included several filmed interviews with one of our project participants. A TB-affected patient and household living in a peri-urban shantytown / slum who was supported by our research project to tackle social and economic challenges associated with TB disease and TB treatment.</gtr:description><gtr:id>1D3F97E1-32BB-401A-9097-56F660846178</gtr:id><gtr:impact>This has been a highly and surprisingly positive experience for the filmed household who have overcome, and put aside the stigma and marginalisation that cause most people living with TB in Peru to keep their contagious disease a secret. 

Further impacts are expected when the World Bank completes and publicises their venture. The involvement of the participant from our project is already complete.</gtr:impact><gtr:title>World Bank empowerment documentary</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>We are working with an independent film maker to publish on Youtube a video describing this project and its potential importance. The video is complete and is now being edited and permission sought from the participants for publication.</gtr:description><gtr:id>F00C5739-CDC9-4AA3-9C84-58A8C3D27C61</gtr:id><gtr:impact>Surprisingly, participation in the filming of this documentary was popular amongst households living with TB, despite the powerful stigma associated with TB. We are exploring the implications of this surprising finding in case helping people living with TB to video their experiences may paradoxically contribute to TB stigma reduction.</gtr:impact><gtr:title>Poverty Warriors Youtube video</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>The Colour Test is a low-cost, low-tech rapid diagnostic tool that we have developed and utilize to diagnose patients with TB in CRESIPT. This tool is particularly useful in that it provides an alternative to high tech and/or expensive rapid diagnostic tools for TB and can find drug resistant strains of TB, which is especially useful in low-resource areas. While we have a written manuscript, we find that an accompanying visual component is helpful in understanding how to develop this tool and provides an alternative to face-to-face training here in Lima. We hope to publish this video with open-access in the Journal of Visualized Experiments, a journal dedicated to distributing accompanying video content.</gtr:description><gtr:id>B83EE5A1-93C6-43DE-BDF5-3DFB3ECC9017</gtr:id><gtr:impact>We aim for this video to be a useful tool for our peers abroad, so that they may be able to utilize the Colour Test in low-resource areas throughout the world.</gtr:impact><gtr:title>Training Video of Production and Utilization of the Colour Test, a TB rapid diagnostic tool</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Municipality of Lima</gtr:collaboratingOrganisation><gtr:country>Peru, Republic of</gtr:country><gtr:description>Municipality of Lima</gtr:description><gtr:id>E4766275-E375-41C1-BD7D-C40D66A8E37F</gtr:id><gtr:impact>It was created the MULTISECTORIAL COMMITTEE TO COMBAT TUBERCULOSIS</gtr:impact><gtr:partnerContribution>They collaborate with the facilities to realize the educational workshops</gtr:partnerContribution><gtr:piContribution>We do TB educational workshops</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>CRESIPT Research Network</gtr:description><gtr:id>4799AD8E-25E3-4F31-9493-B9F7904E6571</gtr:id><gtr:impact>At this early stage the Network have been finalising the project protocol.</gtr:impact><gtr:partnerContribution>Contributions range from active working knowledge and relations with the study communities to informing study design and relevance within the scientific community.</gtr:partnerContribution><gtr:piContribution>Lead research organisation of project award &amp;quot;Community randomised evaluation of socioeconomic intervention to prevent TB&amp;quot;. Manage day to day running of the project. Facilitate, coordinate and initiate collaborative working within the network.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>United Nations (UN)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>World Bank Group</gtr:department><gtr:description>CRESIPT Research Network</gtr:description><gtr:id>80B0B6FB-A49B-46BF-AC4B-F00F0CD1C2FA</gtr:id><gtr:impact>At this early stage the Network have been finalising the project protocol.</gtr:impact><gtr:partnerContribution>Contributions range from active working knowledge and relations with the study communities to informing study design and relevance within the scientific community.</gtr:partnerContribution><gtr:piContribution>Lead research organisation of project award &amp;quot;Community randomised evaluation of socioeconomic intervention to prevent TB&amp;quot;. Manage day to day running of the project. Facilitate, coordinate and initiate collaborative working within the network.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CRESIPT Research Network</gtr:description><gtr:id>197819BF-4468-44E5-BB9C-CBDDAF5E2ED0</gtr:id><gtr:impact>At this early stage the Network have been finalising the project protocol.</gtr:impact><gtr:partnerContribution>Contributions range from active working knowledge and relations with the study communities to informing study design and relevance within the scientific community.</gtr:partnerContribution><gtr:piContribution>Lead research organisation of project award &amp;quot;Community randomised evaluation of socioeconomic intervention to prevent TB&amp;quot;. Manage day to day running of the project. Facilitate, coordinate and initiate collaborative working within the network.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Global TB Program</gtr:department><gtr:description>Public Health partners</gtr:description><gtr:id>A0040AB3-E7AA-4776-AA36-FF0D7032AA72</gtr:id><gtr:impact>Membership of advisory committees, invitation to speak at conferences and meetings.</gtr:impact><gtr:partnerContribution>Input into study design and dissemination of research outputs.</gtr:partnerContribution><gtr:piContribution>Research papers, membership of working groups, presentations at WHO Global TB program meetings</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National TB Reference Laboratory, Tbilisi, Georgia</gtr:collaboratingOrganisation><gtr:country>Georgia</gtr:country><gtr:description>NAMRU-6 in Peru</gtr:description><gtr:id>A60A9ADA-6FBA-47BE-8361-00F73846F2E1</gtr:id><gtr:impact>1) Development of the Color Test for TB diagnosis in low-resource settings
2) Formalised training of physicians and associated healthcare professionals in laboratory methodology with an emphasis on biohazard and biosecurity in mycobaterial diagnosis</gtr:impact><gtr:partnerContribution>1) Our team has provided formal training in laboratory methodology during the past three years for a NAMRU-6 led training course held at el laboratorio de investigacion y desarrollo at the Universidad Peruana Cayetano Heredia
2) Involvement in team research meetings for the past three years</gtr:partnerContribution><gtr:piContribution>1) Collaborative work concerning design of novel TB diagnostics
2) Implementation of novel TB diagnostics in resource-constrained settings</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Callao Regional Directorate of Health</gtr:collaboratingOrganisation><gtr:country>Peru, Republic of</gtr:country><gtr:description>Callao Regional Health Directorate</gtr:description><gtr:id>7DA99D7C-77F4-4953-8B6B-05D6F4B108B8</gtr:id><gtr:impact>The impulse on decrease the time delay to start XDR TB therapy.
The document of priorities of research on Callao.</gtr:impact><gtr:partnerContribution>They give us all facilities to do our research</gtr:partnerContribution><gtr:piContribution>We contribute with the follow-up of the XDR TB patients and thier families doing active screening of TB
We contributed with the meetings about priorities of reseacrh on Callao.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CRESIPT Research Network</gtr:description><gtr:id>4041D3F9-EA1E-4FA8-B584-9ED051669D81</gtr:id><gtr:impact>At this early stage the Network have been finalising the project protocol.</gtr:impact><gtr:partnerContribution>Contributions range from active working knowledge and relations with the study communities to informing study design and relevance within the scientific community.</gtr:partnerContribution><gtr:piContribution>Lead research organisation of project award &amp;quot;Community randomised evaluation of socioeconomic intervention to prevent TB&amp;quot;. Manage day to day running of the project. Facilitate, coordinate and initiate collaborative working within the network.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Callao Regional Directorate of Health</gtr:collaboratingOrganisation><gtr:country>Peru, Republic of</gtr:country><gtr:description>Peru TB Control Strategy</gtr:description><gtr:id>D4865C6D-5D1B-48CD-87C6-1F832EEEA223</gtr:id><gtr:impact>Community workshops for individuals and families of TB patients.</gtr:impact><gtr:partnerContribution>Provide local data and knowledge. Raising the profile of the project with local policy makers and the study communities.</gtr:partnerContribution><gtr:piContribution>Actively working with the local government and civil society TB interest groups to design the study to be of most use and relevance to the communities we are working with.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with IMPACT TB study team</gtr:description><gtr:id>4622D95E-B588-4542-A44E-33B43453D5E0</gtr:id><gtr:impact>1) Presentation on CRESIPT findings at IMPACT-TB meeting in Liverpool March 2017
2) Further presentations and workshops with Nepal and Vietnam National TB Programs planned for late March 2017
3) Funding applications for add-on studies ongoing.</gtr:impact><gtr:partnerContribution>Using methodology developed by our research team, including measurement of TB patient costs and socioeconomic interventions to mitigate such costs, we have been able to develop some add-on studies for IMPACT-TB which will bring added value to their work and disseminate/broaden the impact of the CRESIPT study.</gtr:partnerContribution><gtr:piContribution>The research of our team and our outputs from the CRESIPT study have directly informed the IMPACT TB team. IMPACT TB is an international study involving collaborations with LSTMed, Karolinska Institutet, KNCV, and the National TB Programs of Nepal and Vietnam, examining active case finding.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>World Health Organisation Task Force on Catastrophic Costs of Tuberculosis</gtr:description><gtr:id>06B1FF11-DB3C-47FB-A85C-88249082108F</gtr:id><gtr:impact>1) WHO Global Catastrophic Costs Guidance
2) WHO TB Patient Costs Tool</gtr:impact><gtr:partnerContribution>Previous publications by our team and the ongoing work on the CRESIPT study represent ground-breaking research relating to identifying and addressing catastrophic costs of TB-affected households.

We are continuing to work with WHO to roll out their TB Patient Costs Tool, which draws heavily on our previous methods and employs our catastrophic costs threshold which has been endorsed by WHO in their End TB Strategy.

Tom Wingfield is involved in implementing the Costs Tool in Nepal, Vietnam, and Mozambique.</gtr:partnerContribution><gtr:piContribution>Members of the CRESIPT team are part of the WHO Task Force on Catastrophic Costs.

Previous publications by our team and the ongoing work on the CRESIPT study represent ground-breaking research relating to identifying and addressing catastrophic costs of TB-affected households.

We are continuing to work with WHO to roll out their TB Patient Costs Tool, which draws heavily on our previous methods and employs our catastrophic costs threshold which has been endorsed by WHO in their End TB Strategy.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cayetano Heredia University</gtr:collaboratingOrganisation><gtr:country>Peru, Republic of</gtr:country><gtr:description>CRESIPT Research Network</gtr:description><gtr:id>107F87CD-CC44-4E90-8138-80B0AB9D1612</gtr:id><gtr:impact>At this early stage the Network have been finalising the project protocol.</gtr:impact><gtr:partnerContribution>Contributions range from active working knowledge and relations with the study communities to informing study design and relevance within the scientific community.</gtr:partnerContribution><gtr:piContribution>Lead research organisation of project award &amp;quot;Community randomised evaluation of socioeconomic intervention to prevent TB&amp;quot;. Manage day to day running of the project. Facilitate, coordinate and initiate collaborative working within the network.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Bank Group</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>World Bank</gtr:department><gtr:description>World Bank</gtr:description><gtr:id>4DF49DEF-BDAA-4352-A62B-CE19E0F4F213</gtr:id><gtr:impact>1) Multi-disciplinary collaboration between World Bank staff and our research team in the planning and implementation of a socioeconomic intervention to prevent TB</gtr:impact><gtr:partnerContribution>Regular strategic meetings, contribution to World Bank organised educational and scientific research events, and study site visits by the World Bank and affiliated partners</gtr:partnerContribution><gtr:piContribution>The World Bank has been involved in the planning and development of our socioeconomic intervention to prevent TB.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Naval Medical Research Center Unit-6</gtr:collaboratingOrganisation><gtr:country>Peru, Republic of</gtr:country><gtr:description>NAMRU-6 in Peru</gtr:description><gtr:id>28306C00-0CF3-475A-A87F-A641C041B170</gtr:id><gtr:impact>1) Development of the Color Test for TB diagnosis in low-resource settings
2) Formalised training of physicians and associated healthcare professionals in laboratory methodology with an emphasis on biohazard and biosecurity in mycobaterial diagnosis</gtr:impact><gtr:partnerContribution>1) Our team has provided formal training in laboratory methodology during the past three years for a NAMRU-6 led training course held at el laboratorio de investigacion y desarrollo at the Universidad Peruana Cayetano Heredia
2) Involvement in team research meetings for the past three years</gtr:partnerContribution><gtr:piContribution>1) Collaborative work concerning design of novel TB diagnostics
2) Implementation of novel TB diagnostics in resource-constrained settings</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PRISMA ONG</gtr:collaboratingOrganisation><gtr:country>Peru, Republic of</gtr:country><gtr:description>CRESIPT Research Network</gtr:description><gtr:id>6985E9B9-9C96-4CF5-B6A4-C35BFDC655E3</gtr:id><gtr:impact>At this early stage the Network have been finalising the project protocol.</gtr:impact><gtr:partnerContribution>Contributions range from active working knowledge and relations with the study communities to informing study design and relevance within the scientific community.</gtr:partnerContribution><gtr:piContribution>Lead research organisation of project award &amp;quot;Community randomised evaluation of socioeconomic intervention to prevent TB&amp;quot;. Manage day to day running of the project. Facilitate, coordinate and initiate collaborative working within the network.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>United States Air Force (USAF)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NAMRU-6 in Peru</gtr:description><gtr:id>052091DA-0BDF-448B-8800-AD20D8E5EE71</gtr:id><gtr:impact>1) Development of the Color Test for TB diagnosis in low-resource settings
2) Formalised training of physicians and associated healthcare professionals in laboratory methodology with an emphasis on biohazard and biosecurity in mycobaterial diagnosis</gtr:impact><gtr:partnerContribution>1) Our team has provided formal training in laboratory methodology during the past three years for a NAMRU-6 led training course held at el laboratorio de investigacion y desarrollo at the Universidad Peruana Cayetano Heredia
2) Involvement in team research meetings for the past three years</gtr:partnerContribution><gtr:piContribution>1) Collaborative work concerning design of novel TB diagnostics
2) Implementation of novel TB diagnostics in resource-constrained settings</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GENETUP</gtr:collaboratingOrganisation><gtr:country>Nepal, State of</gtr:country><gtr:description>NAMRU-6 in Peru</gtr:description><gtr:id>42078A76-DFB3-41E1-ACDC-7AB66DCBADDA</gtr:id><gtr:impact>1) Development of the Color Test for TB diagnosis in low-resource settings
2) Formalised training of physicians and associated healthcare professionals in laboratory methodology with an emphasis on biohazard and biosecurity in mycobaterial diagnosis</gtr:impact><gtr:partnerContribution>1) Our team has provided formal training in laboratory methodology during the past three years for a NAMRU-6 led training course held at el laboratorio de investigacion y desarrollo at the Universidad Peruana Cayetano Heredia
2) Involvement in team research meetings for the past three years</gtr:partnerContribution><gtr:piContribution>1) Collaborative work concerning design of novel TB diagnostics
2) Implementation of novel TB diagnostics in resource-constrained settings</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Peruvian Association of Persons Affected by Tuberculosis (ASPAT)</gtr:collaboratingOrganisation><gtr:country>Peru, Republic of</gtr:country><gtr:description>Peru TB Control Strategy</gtr:description><gtr:id>9A5AB6C0-2FB4-4A55-9F70-B59FEE1539D3</gtr:id><gtr:impact>Community workshops for individuals and families of TB patients.</gtr:impact><gtr:partnerContribution>Provide local data and knowledge. Raising the profile of the project with local policy makers and the study communities.</gtr:partnerContribution><gtr:piContribution>Actively working with the local government and civil society TB interest groups to design the study to be of most use and relevance to the communities we are working with.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Regional Government of Callao (Gobierno Regional de Callao)</gtr:collaboratingOrganisation><gtr:country>Peru, Republic of</gtr:country><gtr:description>Peru TB Control Strategy</gtr:description><gtr:id>D1350A93-B720-4085-B1C3-3A51E05104F7</gtr:id><gtr:impact>Community workshops for individuals and families of TB patients.</gtr:impact><gtr:partnerContribution>Provide local data and knowledge. Raising the profile of the project with local policy makers and the study communities.</gtr:partnerContribution><gtr:piContribution>Actively working with the local government and civil society TB interest groups to design the study to be of most use and relevance to the communities we are working with.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NAMRU-6 in Peru</gtr:description><gtr:id>C7855139-7EA4-4912-8D39-F9CCB5B609ED</gtr:id><gtr:impact>1) Development of the Color Test for TB diagnosis in low-resource settings
2) Formalised training of physicians and associated healthcare professionals in laboratory methodology with an emphasis on biohazard and biosecurity in mycobaterial diagnosis</gtr:impact><gtr:partnerContribution>1) Our team has provided formal training in laboratory methodology during the past three years for a NAMRU-6 led training course held at el laboratorio de investigacion y desarrollo at the Universidad Peruana Cayetano Heredia
2) Involvement in team research meetings for the past three years</gtr:partnerContribution><gtr:piContribution>1) Collaborative work concerning design of novel TB diagnostics
2) Implementation of novel TB diagnostics in resource-constrained settings</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Community workshops for people living with TB</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>52C291DD-2D51-4FC2-A18D-3C42892DFA63</gtr:id><gtr:impact>Patients and TB patient groups attended workshops to discuss stigma and depression and how to best address these barriers in TB care locally.

On going activities. The findings are to be used to inform the design of the socio-economic intervention offered to TB patients within the activities of the project.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://more information available at www.ifhad.org</gtr:url><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview on National Station</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8F1A40A8-DB8F-45C3-A01A-8821A21B98FF</gtr:id><gtr:impact>Jimena Castellanos Aguirre was interviewed on national radio program, &amp;quot;Encuentro con la ciencia,&amp;quot; hosted by Modesto Montoya about work with IFHAD.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=yp7t2JVBxro</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Psychiatry Conference 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>687FEA73-376A-4FE8-B4E5-D951C34FBEE3</gtr:id><gtr:impact>Intended purpose is to highlight and increase awareness of TB, mental illness and the best treatment options available.
Hope to spark a discussion and generate further ideas on how to management/support mental illness amongst Tuberculosis in low resourced countries to improve TB outcomes.
Abstract submitted February 2016 and awaiting outcome.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Congress of Clinical Microbiology &amp; Infectious Diseases 2017</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>656EC023-25C9-4456-B194-82F9035B92C3</gtr:id><gtr:impact>Mycobacterium tuberculosis (TB) aerosol droplets pose significant occupational risks, particularly to healthcare workers, who in low and middle-income countries (LMICs) have presented with at least a three-times higher incidence of TB. Assessing the infectiousness of TB patients is particularly challenging, especially in LMICs. Improvement of infectivity detection could have broad impacts on global TB control.
Material/methods: 
We enrolled subjects with suspected TB, with 2+ or 3+ auramine smear, in Lima, Peru and collected clinical, microbiological, radiographic, and cough frequency data. In addition, air-sampling was performed over a 15 minute period of maximally induced cough via a portable 2L/minute vacuum pump onto a PTFE filter with 0.3m pores. Air-sampling was taken on day 0 and 14 of treatment. Air was sampled at 1m distance from the patient's face in an airborne infection isolation room. 
In parallel, we performed serial dilutions of 1 McFarland TB suspension overlaid on filter material, to define the limits of detection of TB on this medium.

The filters were subsequently tested with GeneXpert PCR, standard Microscopic Observation Drug Susceptibility (MODS) assay, MODS with a single-step disinfectant, and MODS with NaOH decontamination. Cultures were assessed up to 8 weeks or until positivity.
Results: 
5 subjects, so far, have been enrolled and completed the two air-samplings. 4 subjects were 3+ on auramine smear at diagnosis, and 1 subject was 2+. All subjects were found to have positive MODS sputum cultures from their day 0 collection. The average time to positive culture was 8.4 days (95% CI: 4.82 to 11.98). Only 1 subject had a positive day 14 MODS culture, which presented after 6 days. All subjects were drug-sensitive on MODS, in all cultures. 
The filters of subjects revealed no positive GeneXpert PCR, nor any positive cultures of MODS with or without disinfectant. Nonetheless, none of the filters developed fungal or bacterial contaminant cultures. 
Results of serial dilution reveals GeneXpert PCR can identify H37RB TB up to 1: 104 McFarland dilution on these filters. It can be assumed that our clinical samples have no greater than this dilution of TB in their aerosol sample.
Conclusions: 
Low-cost effective tests for infectivity of TB patients is needed within LMIC healthcare settings for a quick risk assessment of TB aerosols. Our device, so far, has not shown presence of TB aerosols, despite the subjects having active TB on sputum culture. This could be a result of desiccation of mycobacteria on the filter or TB aerosols being below the threshold of detection. No contamination of cultures reveals the efficacy of the disinfectant, as contamination remains a problem in prior studies.
The concurrent laboratory study will find the threshold of detection of these filters. These studies combined will elucidate the applicability and efficacy of this device. Prior studies have used unique models to measure TB transmission. Current limitations include small sample size. Future studies will further improve low-cost tests for TB infectivity.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The International Union Against TB &amp; Lung Disease 47th Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3DDA63EF-5ABB-46A2-820A-EABC84E2A871</gtr:id><gtr:impact>We presented our finding of TB Active Case Finding in Peru</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The First Peruvian Scientific Conference: Contribution for Tuberculosis Control</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B33695CB-E4B1-40FC-BE6C-5E502D3108FC</gtr:id><gtr:impact>To present the advance of our research and to create networking with the government institutions</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Capacity building - Santa Cruz, Bolivia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FC934028-EFE0-4A80-823A-8E70580CF2AA</gtr:id><gtr:impact>TB, HIV, Chronic infections training day in Santa Cruz, Bolivia. The objective was to share experiences, teach students and capacity build budding researchers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The International Union Against TB &amp; Lung Disease 44th Annual Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A93D3A8D-722B-4901-AB8E-4D775DBB91C4</gtr:id><gtr:impact>To show part of the advance of our research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The International Union Against TB &amp; Lung Disease 46th Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0205745E-8D61-4DCD-B065-1146184FAB17</gtr:id><gtr:impact>Oral presentation &amp;amp; poster discussion session</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Second Peruvian Scientific Conference: Contribution for Tuberculosis Control</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5AE25513-996D-470A-AE8F-F56B815910FD</gtr:id><gtr:impact>To present the advance of our research and to create networking with the government institutions</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with JUNTOS national conditional cash transfer scheme in Peru</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0ABD7CFC-66FD-4CC8-A55B-4AEEE3A8A4EE</gtr:id><gtr:impact>1) Shared experiences with JUNTOS concerning their roll-out nationally of a poverty-reduction conditional cash transfer scheme

1) Devised conditional cash transfers scheme for our intervention
2) Were able to narrow down appropriate bank providers for the conditional cash transfers</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation Belgian NTP - Social Protection</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5A239854-0FA6-4175-BDC1-32160930221C</gtr:id><gtr:impact>To share our experiences in socio-economic protection, and discuss ideas to improve TB care and socio-economic support for the national TB program in Belgium</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Oral presentation and panel discussion - Chagas, TB and HIV conference (Santa Cruz, Bolivia)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E7B0777C-BAB3-4743-80B8-0F97AC5775F5</gtr:id><gtr:impact>Chagas, TB and HIV conference (Santa Cruz, Bolivia) - A conference run in collaboration with Universidad Catholica, Santa Cruz, Bolivia and Johns Hopkins, USA. Dr Datta was asked to present a lecture of TB diagnostics and her research findings. Many people were interested in the work, and new collaborations have been made.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CRESIPT TB Club Film Documentation</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>45C88902-AEEA-4C8F-B046-250DCBE917A0</gtr:id><gtr:impact>Currently developing plans to film the CRESIPT TB Clubs, which will demonstrate the CRESIPT approach to holding social support workshops. The video will feature our team interacting with our participants through a series of activities, including but not limited to: assessment of treatment progression with patients and their families, discussing stigma and discrimination in small groups, educational games, and a group meal. We intend this video to be most useful for our peers, but the video's format will be accessible for the general public as well.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The fourth Annual Peruvian TB Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2F0402BF-D0A8-4AFE-B822-EA78F117EC61</gtr:id><gtr:impact>Present the finding of the some of studies</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research training capacity building programme</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>ED677051-9B8A-48EB-B3E7-F3FFB9BEF036</gtr:id><gtr:impact>I delivered a talk as a part of a research training capacity building programme to local government members and practitioners.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at 46th Union World Conference on Lung Health</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>69982113-3088-4BFF-8A58-2FC8DD39041F</gtr:id><gtr:impact>An invited presentation at a symposium on &amp;quot;Innovative strategies to reach the unreached&amp;quot; at the 46th Union World Conference on Lung Health in Cape Town.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Focus group discussions with participants</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A1FB0792-A2E7-445D-A44E-7B7C81EF902F</gtr:id><gtr:impact>1) Informing and education
2) Participant feedback
3) Refinements of the intervention
4) Responding to participants' issues

1) Refinement of the socioeconomic intervention
2) Set up of facilitator training for participants to assist us in our intervention</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Weekly TB clubs.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C2CEDF04-157D-4CDA-B117-2AFDC8785050</gtr:id><gtr:impact>In the 16 communities receiving the intervention described, we hold weekly community meetings called TB clubs. Approximately 100 TB patients and their family members attend each of these clubs where we discuss multiple aspects of TB prevention, care and cure. These meetings have been very well received with participants frequently attending multiple events.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Focus group discussions with Peruvian National TB Program</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2EBC5DE6-8514-4E96-91E7-308134883E61</gtr:id><gtr:impact>1) Deciding on activity and work in parallel with the healthposts
2) Streamline project activities including collection of patients' sputum samples

1) Refinement of the socioeconomic intervention
2) Discussion of how best to collect and process sputum samples
3) Concerns raised about conditional cash transfers and future sustainability of the project</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview national Peruvian television</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1B18A567-3CB1-4DC8-AB72-22331DAF1179</gtr:id><gtr:impact>Interview on national television during the National Peruvian TB research conference. Presented our findings in TB diagnostic delay, stigma, mitigating TB related costs.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Editorial - Infectious diseases news (USA)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>93ABB0E1-E9F9-4022-98C0-8BF9CD9BEBD1</gtr:id><gtr:impact>Interview on our recent article that was published in clinical infectious diseases.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.healio.com/infectious-disease/respiratory-infections/news/online/%7Ba41b0a57-3cc5-4c25-a2fe-067b00c7c37c%7D/viability-microscopy-predicted-concentration-of-m-tuberculosis-in-sputum-culture</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visiting Lecture - Winter Institute Tropical medicine, Johns Hopkins (Baltimore, USA)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0E7C00FF-E74A-4CB1-93E4-3DAFA0C0DF50</gtr:id><gtr:impact>Giving a talk to Masters students on TB diagnostics and was asked to focus mainly on our research activities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Accepted abstract and oral presentation at 4th National TB Meeting in Peru</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D727CBBE-F9EA-41A2-B849-2148EFBD776B</gtr:id><gtr:impact>Oral presentation at national TB meeting to delegates regarding research project: Opportunities and barriers for reducing costs for TB-affected households to further collaborations to work with the TB programme to carry out interventions to address these damaging excessive patient costs.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Third Peruvian Scientific Conference: Contribution for Tuberculosis Control</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A22B67CE-F848-4DD3-AB4B-65DB59F38C80</gtr:id><gtr:impact>To present the advance of our research and to create networking with the government institutions</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The International Union Against TB &amp; Lung Disease 45th Annual Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7B16382D-9069-41DF-83F4-F09FF0A8905D</gtr:id><gtr:impact>Oral abstracts presentation &amp;amp; Poster discussion sessions

Many other researcher requested more about my findings</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>paper presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral presentation - Royal Free Hospital, Infectious diseases meeting (London, UK)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3A62D593-953B-4DD9-B7DB-F32DB4276EDC</gtr:id><gtr:impact>Discussion of personal research findings and update on ongoing TB research within our group</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Joint 20th Conference of The Union North America Region and the National TB Controllers Association</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E9EFB9A4-A692-4BB5-B051-C0112DEFCAF7</gtr:id><gtr:impact>Two presentations at the above conference.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Working meeting - Peruvian president P. Kuczynski</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C058902B-2A6A-497A-84D7-AE8E5601753F</gtr:id><gtr:impact>The then Presidential candidate requested a meeting with the Prof Carlton Evans and Dr Sumona Datta to present their research, experiences with the TB and the Peruvian health system and discuss ways to improve TB related social protection.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Abstract presentation at the 47th Union World Conference on Lung Health</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>41A6E34A-8B15-4B33-BCF3-EE49F4ED57B6</gtr:id><gtr:impact>20 people from the international research community attended an abstract presentation of the work conducted with IFHAD around the opportunities and barriers to reduce TB-related household costs in Peru; a poster of the project was also available for conference attendees over the 4 days.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral presentation and panel discussion - Imperial College London - Global Health Meeting (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FEBF477D-C920-4263-B000-144AB3E5BA29</gtr:id><gtr:impact>Annual international meeting for Global Health and Innovations at Imperial College London, asked to present recent research findings , and take part in a debate session afterwards with other experts in global health.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>https://www.imperial.ac.uk/global-health-innovation/global-engagement/wellcome-centre-for-global-health-research-annual-meeting/</gtr:url><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International meetings (TB Union, ASTMH)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7A95DFC6-B9EB-4370-85BF-2075CE01329A</gtr:id><gtr:impact>1) Informing other scientific researchers and policy makers of our socioeconomic intervention
2) Keep the scientific community abreast of developments of our research protocol

1) Debate concerning conditional cash transfers
2) Research working groups set up and interaction and sharing of ideas achieved</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Capacity Building Workshop in DIRESA Callao</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1F259C16-F491-47A7-8267-6B81F4DFB119</gtr:id><gtr:impact>Two day capacity building and teaching workshops designed and delivered by members in the research team to a mixed group of delegates from the Regional Health Administrative Centre in Callao. We received positive feedback regarding the open style of teaching and the 'building your own research question' discussion with all members of the team, from fieldwork nurses to experienced senior researcher.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Health personnel capacity building</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8A133009-6015-4BF1-B343-A2BA1636269E</gtr:id><gtr:impact>We have been involved in extensive capacity building with health personnel working at government health posts who deliver TB care. This has predominantly focussed on TB prevention but has also involved TB diagnosis and management of MDR-TB and contacts of MDR-TB. We have received repeated invitations for further capacity building events at these health posts.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visiting Lecture - Summer Institute, Tropical Medicine, Johns Hopkins (Baltimore, USA)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A9274C80-F837-4343-B07D-B5045B68BDFE</gtr:id><gtr:impact>Giving a talk to Masters students on TB diagnostics, was asked to focus mainly on our research activities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Oral presentation and panel discussion  - National TB Program - annual conference (Lima, Peru)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1554CCEA-9B12-41D6-BC6C-1BF318E345D3</gtr:id><gtr:impact>Presenting recent research findings to the audience including national policy makers, sparking discussion and debate about future policies in Peru.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Canada</gtr:country><gtr:currCode>CAD</gtr:currCode><gtr:currCountryCode>Canada</gtr:currCountryCode><gtr:currLang>en_CA</gtr:currLang><gtr:department>Grand Challenges Canada</gtr:department><gtr:description>Grand Challenges Canada Explorations</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Government of Canada</gtr:fundingOrg><gtr:fundingRef>0665-01-10</gtr:fundingRef><gtr:id>74263B42-D2A2-4817-9385-1F3FF0C43985</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Travel Scholarship ASTMH</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>American Society of Tropical Medicine and Hygiene (ASTMH)</gtr:fundingOrg><gtr:id>D4EF457C-6B11-4F8D-9280-C4D34776CC6C</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8980</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Overseas Development Assistance Research Seed Fund</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Higher Education Funding Council for England (HEFCE)</gtr:fundingOrg><gtr:id>71212D23-CE46-4BB6-BE46-2711CC52191E</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3530</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Intergrated Clinical Academic Training Short Experience Fellowship</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>B496A88F-B58D-4635-92F1-331251480700</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>CAD</gtr:currCode><gtr:currCountryCode>Canada</gtr:currCountryCode><gtr:currLang>en_CA</gtr:currLang><gtr:description>Union against TB and lung disease North American Region Conference Travel grant</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>International Union Against Tuberculosis and Lung Disease (The Union)</gtr:fundingOrg><gtr:id>070364AA-C715-4B06-90A7-4235A7698DEA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Travel Grant - Sao Paulo</gtr:description><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:id>576CB648-60F6-47B4-8EA4-D473177034C2</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>CAD</gtr:currCode><gtr:currCountryCode>Canada</gtr:currCountryCode><gtr:currLang>en_CA</gtr:currLang><gtr:description>Travel Grant to attend the Joint 20th Conference of The Union North America Region and the National TB Controllers Association</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>International Union Against Tuberculosis and Lung Disease (The Union)</gtr:fundingOrg><gtr:id>661AD2E2-03A4-4708-85A0-32F3C533A195</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Grant - Birmingham</gtr:description><gtr:fundingOrg>British Infection Association (BIA)</gtr:fundingOrg><gtr:id>8CF27E88-E33E-423F-9F20-3F918BF25AE0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Glasgow Liverpool Wellcome Trust Centre For Global Health Research Flexible Funding Pot</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust (University of Liverpool)</gtr:fundingOrg><gtr:id>302061EE-43AF-490B-95D2-E95849197381</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Innovation for Health and Development Research Fellowship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Imperial College London (ICL)</gtr:fundingOrg><gtr:id>E1E6B3E0-D10C-42A8-8F68-725B73C1029F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Gates Grand Challenges Explorations</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1118545</gtr:fundingRef><gtr:id>E135F9E4-5BFA-403C-B741-8E9066236243</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Primer Grant</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>British Infection Association (BIA)</gtr:fundingOrg><gtr:id>07602C1D-C487-40A2-98DD-C54E42601BD0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Grant to work in a consultancy capacity for World Health Organisation</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:id>5D001516-062D-4655-80EF-F6E43A5BD35A</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>27000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>SEK</gtr:currCode><gtr:currCountryCode>Sweden</gtr:currCountryCode><gtr:currLang>sv_SE</gtr:currLang><gtr:description>Minor Field Studies Grant</gtr:description><gtr:fundingOrg>Swedish International Development Cooperation Agency (SIDA)</gtr:fundingOrg><gtr:id>78946327-190D-4414-AF67-2248AEAF6EF4</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>Peru, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IFHAD Clinical Research Fellowship</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Innovation For Health and Development (IFHAD)</gtr:fundingOrg><gtr:id>D1F48B2C-7B7C-45CA-8E46-ADD955854D6A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Award * 3 persons Vancouver</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>International Union Against Tuberculosis and Lung Disease (The Union)</gtr:fundingOrg><gtr:id>15827F13-E56F-40B4-8A42-8030753929D3</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>251068</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Research Training Fellowship</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>201251/Z/16/Z</gtr:fundingRef><gtr:id>3BE85B71-D8DC-486B-9F39-C30993B5D41A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>196000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Global Emerging Infection Surveillance and Response ...GEISS</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>United States Department of Defense via NAMRU-6</gtr:fundingOrg><gtr:fundingRef>Constitutes 165,000 USD contract for our team research plus  31,000 USD for collaborative activities</gtr:fundingRef><gtr:id>95B15E61-3463-4065-8D38-9F49BD8CD3CE</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700</gtr:amountPounds><gtr:country>Sweden, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel grant to Social Protection Action Research and Knowledge Sharing (SPARKS) network meeting</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Karolinska Institute</gtr:fundingOrg><gtr:id>25C08E0E-E0DA-43F7-9383-752EE95807B4</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>Peru, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fellowship for Dr Tom Wingfield</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Innovation For Health and Development (IFHAD)</gtr:fundingOrg><gtr:id>B700C6FA-1B76-4363-A221-2CF3663615B4</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>363000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Clinical Research Training Fellowship</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust/EPSRC</gtr:fundingOrg><gtr:id>2D8D6B1C-AF5A-4B42-A6CB-980445EA75FE</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7000</gtr:amountPounds><gtr:country>Peru, Republic of</gtr:country><gtr:currCode>PEN</gtr:currCode><gtr:currCountryCode>Peru</gtr:currCountryCode><gtr:currLang>es_PE</gtr:currLang><gtr:description>The travel grant to attend to the 47th Union World Conference on Lung Health Liverpool, UK: 26 October - 29 October 2016</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Innovation For Health and Development (IFHAD)</gtr:fundingOrg><gtr:id>74273236-6ADC-430D-B698-7BF0315C6FC3</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>130000</gtr:amountPounds><gtr:country>Peru, Republic of</gtr:country><gtr:currCode>PEN</gtr:currCode><gtr:currCountryCode>Peru</gtr:currCountryCode><gtr:currLang>es_PE</gtr:currLang><gtr:description>CONCYTEC Grand Challenge Explorations</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>National Council for Science, Technology and Technological Innovation (CONCYTEC)</gtr:fundingOrg><gtr:fundingRef>0XX-2014</gtr:fundingRef><gtr:id>C02C4425-7D50-4AE7-9D71-4D06376EF1F6</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Travel Award - Paris</gtr:description><gtr:fundingOrg>International Union Against Tuberculosis and Lung Disease (The Union)</gtr:fundingOrg><gtr:id>36129925-E744-4DF7-8EFE-DAC15B017A0E</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel Grant</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>International Union Against Tuberculosis and Lung Disease (The Union)</gtr:fundingOrg><gtr:id>05116E4E-3400-460E-BC17-E503100018E7</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Global Emerging Infection Surveillance and Response ...GEISS</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>United States Department of Defense via NAMRU-6</gtr:fundingOrg><gtr:fundingRef>Constitutes 120,000 USD contract to our team and 80,000 for collaborative work</gtr:fundingRef><gtr:id>7976F145-1D96-44F8-84C4-71D3499B635F</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Imperial College London Wellcome Trust Infection and Global Health Research Annual Meeting: for 3 people</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Imperial College London (ICL)</gtr:fundingOrg><gtr:id>9B0BADB2-C22B-4FC3-B92C-016A5F4396C9</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Travel Scholarship International Union</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>International Union Against Tuberculosis and Lung Disease (The Union)</gtr:fundingOrg><gtr:id>C70352E5-5986-4A38-BD56-42F89E11DBFC</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>32228</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:department>Fogarty International Centre</gtr:department><gtr:description>National Institutes of Health Fogarty Global Health Fellowship</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>R25TW009340</gtr:fundingRef><gtr:id>95EFD065-ADAE-43D3-8E46-B5ED7423B9BF</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Travel Award - Bahia</gtr:description><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:id>F84EE6CC-DB35-439F-80B9-ACEB0E5F0044</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Union against TB and lung disease North American Region Conference Travel grant</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>International Union Against Tuberculosis and Lung Disease (The Union)</gtr:fundingOrg><gtr:id>9E2F0027-DC48-492E-9903-88B8571F44C5</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR/Wellcome Trust Imperial Clinical Research Facility</gtr:department><gtr:description>Imperial College Global Health Clinical Fellowship Scheme ISSF</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Imperial College London (ICL)</gtr:fundingOrg><gtr:id>A16FA3FA-8C42-4ED4-AD2C-7228E7D74CD0</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Johns Hopkins Bloomberg School of Public Health - the Dean's Scholarship</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Johns Hopkins University</gtr:fundingOrg><gtr:id>3107C27C-2460-40B5-96C6-DEBFE9A2C563</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>The travel to attend to the 44th Union World Conference on Lung Health. Paris, France: 31 October - 4 November 2013</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>International Union Against Tuberculosis and Lung Disease (The Union)</gtr:fundingOrg><gtr:id>0E4CD080-AC1B-4BFD-A760-F55DFB386FE6</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Travel Grant - Sao Paulo</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>United States Agency for International Development</gtr:fundingOrg><gtr:id>CB090E65-2CE8-4F8D-B4B2-DFBDEB5DE02B</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1250</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences Young Investigator Award 2017</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>F413B627-B19E-4DC8-BCB7-745E303B66F8</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Health Promotion Workers TB Training Workshop</gtr:description><gtr:geographicReach>South America</gtr:geographicReach><gtr:id>7594D876-C018-41EF-88A9-719FB0B70FB0</gtr:id><gtr:impact>This important workshop for frontline health promotion workers in Ventanilla was an essential part of disseminating the results of our research in a way that directly impacted the population we serve through our work. These health workers provide regular house visits and foster relationships with the most in need communities in order to provide essential education and guidance towards accessing healthcare appropriately and promptly. We trained these individuals with a series of talks and open peer discussion with the results of our work so far around risk factors for TB, advising how to overcome the barriers to accessing healthcare and around reducing simple daily costs which could all make a significant benefit to patient and household TB outcomes as well as build the basis for future engagement and collaboration.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Collaboration with Peru's National TB Strategy</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6465B5BB-DE62-4582-BCDE-54365F522955</gtr:id><gtr:impact>Qualitative data arising from a research study that investigated the social determinants that contribute to diagnostic delay has been and is continuing to be reviewed by leaders in the National TB Strategy of Peru. This data will be used to modify and/or implement policy that may change relationships between patients and their various healthcare providers to reduce diagnostic delay of tuberculosis disease.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>The new post-2015 TB elimination strategy</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B62F1695-819A-4D78-9C34-713619321C9F</gtr:id><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Reducing TB patient costs and lost income during illness</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>7C571311-9482-4999-A7BE-F2BE6317A130</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Task force on UHC social protection - subgroup on measurements</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>972E15FE-27DD-4726-81BD-D7B61227EA15</gtr:id><gtr:impact>This is part of the World Health Organisation global TB program post-2015 draft TB control strategy. Thus this group is influencing policy that will have health and economic impacts.</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Implementation of the use rapid molecular DST</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5AB9D831-A810-4F46-AFFD-441B966F48B5</gtr:id><gtr:impact>The patients have a screeing of MDR TB on the same day they are diagnosed by TB</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Training to principles TB laboratory focusing on tuberculosis diagnosis and biosefaty</gtr:description><gtr:geographicReach>South America</gtr:geographicReach><gtr:id>17862EDD-FA7B-4E53-A63E-34E78CD83F09</gtr:id><gtr:impact>During this period of time, our TB laboratory in Cayetano Heredia University collaborated with the NAMRU-6 in Lima, Peru in order to implement the basic conditions to develop tuberculosis diagnosis using simple and practical conditions specially with the military laboratories from Guatemala, Belize, El Salvador, Nicaragua, Honduras, Dominican Republic, Colombia and Peru also. The useful for this kind of training was very useful to develop strategies to develop tuberculosis diagnosis and to improvement the biosafety conditions.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>The New TB elimination strategy</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E1FDC1C0-43D8-4C67-A9E6-97F5306410E7</gtr:id><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>TB preventive therapy</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>51710912-3E5B-4FB5-9818-DCCB6F77735A</gtr:id><gtr:impact>We have been extensively involved with the Peruvian NTP aiming to increase coverage of TB preventive therapy. Our data analysis and evidence presented at various meetings has led to the NTP endorsing a new policy for which contacts should receive TB preventive therapy. We are currently evaluating this policy as part of our study. This new policy aims to increase coverage of TB preventive therapy, reduce TB incidence in household contacts, and ultimately therefore improve quality of life.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Collection of qualitative data on the social determinants that contribute to diagnostic delay of tuberculosis has been completed. This data has been used to help develop and refine TB Clubs aimed to reduce the social stigma surrounding tuberculosis disease. The principle source of funding for this work has been a research fellowship granted for Lily Bonadonna by the Innovation for Health and Development (IFHAD) group.</gtr:description><gtr:id>D12B1384-0C6A-41CA-901F-F45E80FEE318</gtr:id><gtr:impact>The development of these TB clubs has shown us the important use and need for qualitative data while designing social interventions.</gtr:impact><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>Qualitative Background on Reducing Stigma</gtr:title><gtr:type>Health and Social Care Services</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Qualitative and quantitative research was done to explore the most essential components of providing social support to persons affected by tuberculosis. Focus groups with international researchers, field team nurses responsible for operational functions of CRESIPT, contacts of persons diagnosed with TB, and persons diagnosed with TB were conducted. Additionally, each of these groups were asked to write and rank what they believed were the three most essential components of providing social support. This knowledge has been used in guiding the delivery of social support in the CRESIPT study.</gtr:description><gtr:id>F87BC3DB-A869-4AD6-8289-C63190F0E589</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in its delivery phase.</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Methods to Providing Social Support</gtr:title><gtr:type>Therapeutic Intervention - Psychological/Behavioural</gtr:type><gtr:yearDevCompleted>2017</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>The TB Stigma Reduction Program, based on cognitive behavior therapy techniques, serves as the foundation for the CRESIPT TB Club Support Groups (see entry in &amp;quot;Medical Products, Interventions and Clinical Trials&amp;quot; section). This interactive program is designed to guide people with TB and their family members through a series of predetermined questions and self-selected responses to aid them in identifying emotions, thoughts, and behaviors associated with their personal experience of TB stigma, and explore alternative thoughts and behaviors intended to empower them in identifying and resisting TB stigma, adhering to and completing TB treatment, and having family members tested for TB. Peer mentors conduct the support groups and facilitate members' use of the program. The TB Stigma Drawings Booklet (see entry in &amp;quot;Artistic and Creative Products&amp;quot; section) is employed in conjunction with the program.

This intervention is currently in the implementation and evaluation stage at multiple sites with large numbers of participants.

Funding for this project falls under that provided for CRESIPT.</gtr:description><gtr:id>D4CDF4C2-637A-4B77-90ED-6D6C55D6724A</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in the delivery phase.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>TB Stigma Reduction Program (TBSRP)</gtr:title><gtr:type>Therapeutic Intervention - Psychological/Behavioural</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Socio-economic support package to be offered to TB patients alongside the standard medical care that is already offered in Peru. The socio-economic support package is being assessed as to its value for reducing bad outcomes for TB patients and reducing risk factors within TB affected households.</gtr:description><gtr:id>F5C90431-D534-4F49-B3F0-FF3D5FD25046</gtr:id><gtr:impact>Still under development due to begin testing in the coming months.</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Socio-economic support package for people lving with TB</gtr:title><gtr:type>Health and Social Care Services</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>TB is difficult to diagnose in low-resource settings that have limited access to laboratories with adequate biosafety. The Colour Test is a low-cost and low-intensity method of diagnosing TB and resistant TB using thin layer agar colour plates. We aim to be able to roll-out the Colour Test to relevant areas for assessment and do not intend to patent this product.</gtr:description><gtr:id>32119C1B-DE5F-48E8-9689-6420DAD26138</gtr:id><gtr:impact>The Colour Test findings have been presented at international meetings and published in international journals (see below). Assessment and evaluation is still ongoing.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Colorimetric thin-layer agar test to diagnose TB in resource-constrained settings (The Color Test)</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/22762424</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>As part of this study, we are currently evaluating a cash transfer intervention to incentivise and enable access to TB care. This specific economic intervention has evolved through various consultations, planning meetings and experience in the field.</gtr:description><gtr:id>BAF25D87-47CE-4648-9648-22DADBF8AB49</gtr:id><gtr:impact>This intervention is currently under evaluation.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>CRESIPT cash transfer intervention</gtr:title><gtr:type>Preventative Intervention - Behavioural risk modification</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Using an old technique of viability assessment with Flouerscein diacetate now adapted to be used with Mycobacterium tuberculosis, we are assessing its role in monitoring treatment response and infectiousness screening in tuberculosis. We have improved the protocol so it can be used in all resource constraint settings, to highlight those not responding to treatment within days of commencement. This will be the first tool of it's kinds, and appropriate from rural to industrialised settings.</gtr:description><gtr:id>155D825B-746F-4DA8-99E3-00493D4304D5</gtr:id><gtr:impact>Please see papers below:
1. Datta S, Sherman JM, Bravard M, Valencia T, Gilman RH, Evans CA. Clinical Evaluation of Tuberculosis Viability Microscopy for Assessing Treatment Response. Clin Infect Dis 2014;ciu 1153.:
2. Lawn SD, Nicol MP. Editorial commentary: dead or alive: can viability staining predict response to tuberculosis treatment? Clin Infect Dis 2015;60:1196-8.</gtr:impact><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Viability microscopy</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2015</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Mutual support groups, guided by peer mentors, employ TB Stigma Drawings Booklets (see entry in &amp;quot;Artistic and Creative Products&amp;quot; section) and an interactive TB Stigma Reduction Program (see entry in &amp;quot;Medical Products &amp;amp; Interventions&amp;quot; section) to support people with TB and their family members in identifying and resisting TB stigma, adhering to and completing TB treatment, and having family members tested for TB. Through sharing common experiences, emotions, and thoughts, a sense of common identity and solidarity may emerge, forming a supportive social network that through peer mentor guidance may serve as a foundation for a TB civil society organization (see entry in &amp;quot;Other Outputs &amp;amp; Knowledge/Future Steps&amp;quot; section) to further support and empower people with TB and their family members. 

This intervention is currently in the implementation and evaluation stage at multiple sites with large numbers of participants.

Funding for this project falls under that provided for CRESIPT.</gtr:description><gtr:id>28A4AB4E-BA00-43DF-A3FE-1FC45842819A</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in the delivery phase.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>TB Club Support Groups (TBCSG)</gtr:title><gtr:type>Therapeutic Intervention - Psychological/Behavioural</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Peer mentors -- people with TB who are participants in the CRESIPT study and are no longer infectious -- provide support to people with TB and their family members newly-enrolled in the CRESIPT study. Peer mentors receive basic orientation in TB disease, transmission, diagnosis and treatment; sputum sample collection and transportation; TB stigma; and how to conduct TB clubs. Peer mentors perform home visits; accompany individuals and their families in obtaining testing for TB; collect and deliver TB sputum samples; assist people with TB to adhere to and complete TB treatment; inquire about TB medication side-effects; and conduct educational workshops and TB stigma reduction and empowerment support groups that are a part of TB clubs.

This intervention is currently in the implementation and evaluation stage at multiple sites with large numbers of participants.

Funding for this project falls under that provided for CRESIPT.</gtr:description><gtr:id>C912D12C-A10E-4ABE-B10E-0C4DEF907794</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in the delivery phase.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Peer Mentors</gtr:title><gtr:type>Preventative Intervention - Behavioural risk modification</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>TB Clubs, guided by peer mentors, meet weekly at multiple sites throughout local communities in which the intervention limb of the CRESIPT study is being conducted. TB Clubs include both an educational workshop component and a support group component (see respective entries in &amp;quot;Medical Products, Interventions, and Clinical Trials&amp;quot; section). Overall objectives of the TB Clubs include educating participants about TB; reducing TB stigma; facilitating TB treatment adherence and completion among people with TB and TB testing of family members; creating a common identity, solidarity, and social support network among local community TB Club participants; and establishing a TB civil society organization to empower people with TB and their families at the local, departmental, and national levels.

This intervention is currently in the implementation and evaluation stage at multiple sites with large numbers of participants.

Funding for this project falls under that provided for CRESIPT.</gtr:description><gtr:id>7D145F9C-B291-4E65-83C2-8D0715505444</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in the delivery phase.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>TB Clubs</gtr:title><gtr:type>Preventative Intervention - Behavioural risk modification</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Educational TB workshops, guided by peer mentors, employ interactive group participation activities to create a safe, non-judgemental environment and sense of cooperative group identity in which to communicate basic information regarding TB disease, transmission, diagnosis, treatment, and prevention; nutritional supplementation; and TB-related stigma. 

This intervention is currently in the implementation and evaluation stage at multiple sites with large numbers of participants.

Funding for this project falls under that provided for CRESIPT.</gtr:description><gtr:id>CCBC40EB-96AD-4491-86CD-28EEE18F0C16</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in the delivery phase.</gtr:impact><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>TB Club Educational Workshops (TBCEW)</gtr:title><gtr:type>Preventative Intervention - Behavioural risk modification</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>We have developed a simple TB risk score that can predict which contacts of patients with TB are at high risk of disease. We are currently evaluating, validating and refining this score using prospectively collected data. We aim to increase the number of contacts completing TB preventive therapy through informing them of their risk of TB.</gtr:description><gtr:id>BEAF6DFA-C85D-4F68-B2EC-2792105268AE</gtr:id><gtr:impact>Identification of TB risk factors among household contacts.</gtr:impact><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>TB risk score</gtr:title><gtr:type>Preventative Intervention - Behavioural risk modification</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>We are currently in the process of transforming our data collection from paper to tablet based questionnaires. We have piloted this system already with great success. Data are collected in the field and automatically uploaded to the cloud when the field member has internet connection. Data can then be downloaded directly from a secure cloud service, without any digitisation.</gtr:description><gtr:id>2A1A741C-150D-4EDE-A9A9-EB2DE9967783</gtr:id><gtr:impact>More efficient data collection with no digitisation errors.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Tablet based data collection</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>We have updated our database to make it more intuitive for our data team. This includes using images of the questionnaire to facilitate easy data entry and minimise error rates. The database is relational enabling us to rapidly and easily identify key data. We have developed automated systems enabling use to facilitate rapid bank transfers to patients recruited to the intervention. We have also developed a simple and intuitive system for digitising patient TB card data that enables us to easily view and update these data.</gtr:description><gtr:id>7FB67E2C-90F0-45B2-9574-8090F7874E7B</gtr:id><gtr:impact>We have observed a reduction in our error rates and have improved the efficiency of our complex field processes.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Automated relational database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>This award involves collection of intrinsically complex data.

Data domains include communities, households, people, illnesses, treatment episodes, interviews, diagnostic samples, diagnostic test results and most study participants have data in most of these domains on multiple occasions. We have developed a relational database that efficiently manages these complex data. 

In preference to tablet computer-based systems that pose too great a staff security risk in our impoverished setting, we have developed a simple unidirectional paper-based data management system with integrated quality control and double digitisation.

Importantly for our setting, we have also integrated a system of daily confidential, secure data backup to the 'Cloud' to ensure data security.

This is integrated with the laboratory data management system that we have developed and is described in the software section.</gtr:description><gtr:id>CCFC50FB-B143-4365-94BF-2D0BE4FB5C66</gtr:id><gtr:impact>These achievements have already had a major impact on the efficiency and productivity of our research team and ongoing project.

Later in the project we plan to publish and share these resources that we have developed.

We have already committed to making all data from this project widely available through anonymised inclusion in an online data repository, as required by the grant conditions.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CRESIPT study database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have adapted the Internalized Stigma of Mental Illness Scale (ISMIS) to measure TB self-stigma among people with TB. The ISMIS is a validated research tool developed to measure self-stigma among people with psychiatric disorders. Our TB-adapted questionnaire is being administered to participants in both the intervention and control groups of the CRESIPT study, both pre- and post-intervention, in order to establish baseline measurements of existing TB self-stigma, and demonstrate the effect of a TB self-stigma reduction intervention.</gtr:description><gtr:id>A2823ACD-4648-49CC-A04E-0A71B6308F63</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in its delivery phase.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>TB Self-stigma Questionnaire</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Created and implemented a TB knowledge questionnaire to highlight knowledge gaps. This is a self-rated questionnaire of multiple choice questions related to TB care, and health rights.</gtr:description><gtr:id>95FB1DFD-9FFB-490E-A693-6E6AC496AB0A</gtr:id><gtr:impact>Knowledge gaps will be addressed to tailor educational activities to improve TB control, and health related advocacy</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>TB knowledge questionnaire</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have adapted the Explanatory Model Interview Catalog (EMIC) to measure negative beliefs, attitudes, and fear of discrimination related to TB among people both with and without TB. The EMIC is a validated research tool developed to identify patterns of distress, perceived causes, help-seeking and treatment preferences, and general illness beliefs from the experience and perspective of people directly affected by a particular illness.
 Our TB-adapted questionnaire is being administered to participants in both the intervention and control groups of the CRESIPT study, both pre- and post-intervention, in order to establish baseline measurements of these stigma components and demonstrate the effect of a TB stigma reduction intervention. 
 In addition, non-TB-affected members of the same communities, not participating in the CRESIPT study, are also being surveyed to establish baseline measurements of these TB stigma components among this group.</gtr:description><gtr:id>3091C023-20ED-485F-B9BB-85827FF4A0BC</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in the delivery phase.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Internalized TB Beliefs, Attitudes, and Fear of Discrimination Among People Without TB Questionnaire</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>For data collection, data entry and database management, and laboratory techniques, a paired system of quality assurance has been developed and implemented. Team members are responsible for pairing monthly with another team member to monitor and evaluate if research methods adhere to team protocols. Team members follow a guided checklist of essential research methods and correct non-adherences if they appear.</gtr:description><gtr:id>69705C83-87C4-47AE-9C15-B62260D2C8D7</gtr:id><gtr:impact>A systematic quality assurance program ensures better data collection, data entry and database management, and laboratory procedures.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Quality Assurance</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>At present, there is no agreed consensus defining intermittent adherence. In order to address this knowledge gap, we aimed to create an operational definition of intermittent adherence during the two phases of DOTS, characterise its association with clinical and socioeconomic risk factors and examine its association with the risk of TB recurrence.</gtr:description><gtr:id>E483E37B-8BA9-4FDD-980D-2FCDE8F81678</gtr:id><gtr:impact>It is important to establish a standardized clinically-relevant threshold to classify intermittent or irregular adherence in order to allow comparison of adherence rates and clinical relevance in future studies.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>TB Intermittent therapy definition</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>TB culture often is marred by contamination from comensal bacteria and fungi, often reducing the quality of results. A single step decontamination with trisodium phosphate prior to placement of TB samples into standard Lowenstein-Jensen (LJ) media, has been noted to reduce growth of contaminant fungi in TB cultures. Our lab uses a trisodium phosphate solution, where the samples are placed for 20 minutes and then transferred to the LJ media.</gtr:description><gtr:id>CDC39E77-C039-4B85-B49F-F0180EABD2B8</gtr:id><gtr:impact>This single step decontamination was used in the assessment of TB aerosol filters as a measure of infectivity of TB patients. In all clinical aerosol filter samples, no fungi or bacterial contamination was found following single step decontamination. In a concurrent validation experiment with fungi and TB, the single step decontamination also proved effective in decreasing fungal overgrowth.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Single Step decontamination for TB cultures</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have adapted the Explanatory Model Interview Catalog (EMIC) to measure anticipated TB stigma among people with TB. The EMIC is a validated research tool developed to identify patterns of distress, perceived causes, help-seeking and treatment preferences, and general illness beliefs from the experience and perspective of people directly affected by a particular illness.
 Our TB-adapted questionnaire is being administered to participants in both the intervention and control groups of the CRESIPT study, both pre- and post-intervention, in order to establish baseline measurements of existing anticipated TB stigma, and demonstrate the effect of an anticipated TB stigma reduction intervention.</gtr:description><gtr:id>43CE0286-A807-4190-B81B-949B61A26911</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in its delivery phase.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Anticipated TB Stigma Questionnaire</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Adapted the WHO euroHISQOL-8 questionnaire to be applicable to our participants affected by tuberculosis living in peri-urban shantytowns, in a non english speaking country.</gtr:description><gtr:id>D2DEF233-F51C-491F-A6CC-7C12FF3A0130</gtr:id><gtr:impact>If we can show that wellbeing score can highlight the most vulnerable people, it could be used in clinical settings as screening for the most vulnerable and require extra support.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Wellbeing - Tuberculosis</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A mixed-methods questionnaire tool was designed, tested and developed in the field to estimate to what degree indirect and direct costs incurred by TB patients are preventable or can be reduced.</gtr:description><gtr:id>569C8EC0-C88E-45C1-BDB5-72FDBC037203</gtr:id><gtr:impact>First group to knowingly describe this outcome measure.
Assists in the innovation of interventions to reduce these costs and prevent catastrophic costs - therefore addressing the new Stop TB and WHO priorities focussed around social protection and eradicating catastrophic costs for TB affected households.
These interventions will then be carried out and evaluated, then the findings disseminated to share with other research communities globally.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Tool to estimate 'preventability' of direct and indirect TB related costs</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Best evidence based supportive/treatment measures used to address mental health issues amongst TB patients to improve TB treatment compliance and TB outcomes.</gtr:description><gtr:id>14D19731-D409-436C-8D59-2E7BA59AB37F</gtr:id><gtr:impact>Initial development stage. Publication is in progress.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Supportive measures addressing mental health issues amongst TB patients</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Data collection instruments aiming to assess the socio-economic position (poverty), depression, stigma and TB risk factors of patients and people at risk of becoming TB patients.</gtr:description><gtr:id>FF25C50D-9965-4210-A422-0A0337406923</gtr:id><gtr:impact>This tool is in development stage, due to be piloted in the coming months. We have shared it freely with collaborators and anyone who requests it, in order to facilitate their research and work.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Data Collection Instruments</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A survey was conducted during a 6 month period of the initial pilot phase of the CRESIPT study in which people with TB and their family members, after having participated in TB workshops that included TB-stigma and empowerment education, were each asked to provide 5 words that best described what TB stigma and empowerment meant to them. These responses were then collated to create 2 shortened lists of the most frequently-used words to describe TB stigma and empowerment. These 2 shortened lists were then used to inform the development of a cognitive behavior therapy-based TB support group intervention to reduce anticipated and TB self-stigma, and empower people with TB and their family members to achieve TB diagnosis and cure.</gtr:description><gtr:id>F43A7D7C-EBE6-404B-A691-FA41CB0A6B12</gtr:id><gtr:impact>The impact of this research is still being evaluated as the CRESIPT study is currently in the delivery phase.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>&quot;5 Words&quot; Survey</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Definition of catastrophic costs for TB-affected families has been unclear. We devised a definition that was both locally-appropriate and clinically-relevant.</gtr:description><gtr:id>1FFFFC96-854C-401F-A913-91F83C90427D</gtr:id><gtr:impact>We were able to develop this with the WHO working group on social protection and UHC. This has since been published in PLOS Medicine to be used as an example for other research groups.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Catastrophic costs measurement methodology</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001675</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Currently developing a training video of ventilation methods, based on the work of Richard Menzies and A. Roderick Escombe. Ventilation is crucial in the prevention of TB, a complement to isoniazid prevention therapy in TB patients household contacts. It is our hope that producing this video facilitate our peers' utilization of this low-cost, low-tech method. We hope to publish this video in the Journal of Visualized Experiments (JoVE), a journal dedicated to distributing video content to researchers.</gtr:description><gtr:id>D0ECCA79-2F6D-4777-959E-4A6723A472B0</gtr:id><gtr:impact>Once the video is distributed in JoVE, we hope that our peers abroad may be able to use this tool in order to prevent new infections of TB worldwide.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Training Video of Ventilation Methods</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>A mobile phone application version of our TB risks core</gtr:description><gtr:id>4F100552-9E97-41B8-8779-684011880B02</gtr:id><gtr:impact>We are currently in the process of developing this app and will evaluate its potential for field use.</gtr:impact><gtr:title>TB risk score application</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>The award involves a marked, and challenging increase in TB diagnostic testing by our laboratory, providing participants and the research with TB screening and TB drug-resistance testing.

In trying to address this challenge, we noted that our lab team actually spend much longer handling information than handling samples. Checking a sample is quick, finding the right place to record and collate the information is more time consuming. This is because each sample has several tests, each checked on multiple days, so the information flow is quite complex.

We were not the first to note this challenge and several companies have developed elegant computerised systems but these are expensive and just as importantly, inflexible. They would require us to fly in an expert programmer from the company every time we change our procedures, which would be inappropriate for a research team like ours.

We are therefore developing and plan to publish an 'open access' data management system for diagnostic laboratories. Although developed for TB, it will likely be valuable for other diseases too.</gtr:description><gtr:id>F1ACE263-DF46-49B3-9B9D-57F1907E0B66</gtr:id><gtr:impact>We have completed the first phase. All data associated with a sample is now attached on a miniature paper form to the test. This simple, but highly usual step, means that parallel systems for tests and forms are eliminated. For example, 500 TB diagnostic cultures in our incubators are no longer associated with 500 paper forms in folders that have to be found, cross-checked and updated several times each week for 6 weeks. Rather, all data is now attached to the ongoing culture in the incubator, and can be updated in a moment each time the culture is checked. Although this sounds simple, it is highly unusual or unique in TB laboratories and relies upon the second innovation, that these potentially contaminated, potentially infectious forms are then digitally photographers that the digital image is digitised, without exposing administrative staff to any infection risk. These simple innovations have remarkably increased efficiency and increased capacity to provide research diagnostic information for more participants.

The current second phase is developing a flexible, simple, open access 'freeware' tablet computer system for replacing the paper forms. We have obtained independent research funding for this venture ($20,000 USD) and this is in progress with collaborators in NAMRU-6.</gtr:impact><gtr:openSourceLicense>true</gtr:openSourceLicense><gtr:title>Appropriate technology TB diagnostic laboratory result management system</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D49A5B35-3015-4989-AFE2-5CB106A48705"><gtr:id>D49A5B35-3015-4989-AFE2-5CB106A48705</gtr:id><gtr:title>Analysis and reporting of stepped wedge randomised controlled trials: synthesis and critical appraisal of published studies, 2010 to 2014.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8772bdefc0171096ff17c4c62ec90aca"><gtr:id>8772bdefc0171096ff17c4c62ec90aca</gtr:id><gtr:otherNames>Davey C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CEE67B27-F3C2-4F1F-830D-C19260831707"><gtr:id>CEE67B27-F3C2-4F1F-830D-C19260831707</gtr:id><gtr:title>Multi-drug resistant TB acquisition during clinic-based directly-observed therapy predisposes to adverse patient outcomes</gtr:title><gtr:parentPublicationTitle>International Journal of TB &amp; Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/724489504998fa96747397d35c8f1c08"><gtr:id>724489504998fa96747397d35c8f1c08</gtr:id><gtr:otherNames>Tovar MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/858CB520-BBEA-48FB-AE4B-6C17241F4200"><gtr:id>858CB520-BBEA-48FB-AE4B-6C17241F4200</gtr:id><gtr:title>Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/238ad7f9017022ec1e1d4558cc46c3d7"><gtr:id>238ad7f9017022ec1e1d4558cc46c3d7</gtr:id><gtr:otherNames>Hoffmann CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FBA150EB-D4F8-4B81-9E4E-D237CEEFFA4E"><gtr:id>FBA150EB-D4F8-4B81-9E4E-D237CEEFFA4E</gtr:id><gtr:title>Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/75db9f1ec0f1fe6ba8ee11e98ea71fa4"><gtr:id>75db9f1ec0f1fe6ba8ee11e98ea71fa4</gtr:id><gtr:otherNames>Letang E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/460A51EC-3F35-42E7-AE2F-C21427F9F2CC"><gtr:id>460A51EC-3F35-42E7-AE2F-C21427F9F2CC</gtr:id><gtr:title>TB-related dissaving was common and correlated with incurring catastrophic costs in TB-affected households in Peruvian shantytowns</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA6BD67D-3104-417D-B3F9-9CAC20B2EC92"><gtr:id>DA6BD67D-3104-417D-B3F9-9CAC20B2EC92</gtr:id><gtr:title>A novel socioeconomic intervention improves TB cure and chemoprophylaxis completion in Peruvian shantytowns: a randomized controlled evaluation</gtr:title><gtr:parentPublicationTitle>International Journal of TB &amp; Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8DBF16B-7D03-430A-9369-601EF4963FA1"><gtr:id>B8DBF16B-7D03-430A-9369-601EF4963FA1</gtr:id><gtr:title>Designing and implementing a socioeconomic intervention to enhance TB control: operational evidence from the CRESIPT project in Peru.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5AB4B8B-BBDD-4D53-88A7-3FC4E2D30CE2"><gtr:id>B5AB4B8B-BBDD-4D53-88A7-3FC4E2D30CE2</gtr:id><gtr:title>&amp;quot;Proof-of-concept&amp;quot; evaluation of an automated sputum smear microscopy system for tuberculosis diagnosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/767e26e459f263f3a394b81f5455d1db"><gtr:id>767e26e459f263f3a394b81f5455d1db</gtr:id><gtr:otherNames>Lewis JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9AEFB0FC-E796-471F-A63F-E18A3DA718C9"><gtr:id>9AEFB0FC-E796-471F-A63F-E18A3DA718C9</gtr:id><gtr:title>Tuberculosis-related knowledge is associated with patient outcomes in shantytown residents; results from a cohort study, Peru.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/46d8b995e6934a478425fdaca902a36e"><gtr:id>46d8b995e6934a478425fdaca902a36e</gtr:id><gtr:otherNames>Westerlund EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/836D1CF9-02AA-4F2B-AFEB-698C93BFD9D3"><gtr:id>836D1CF9-02AA-4F2B-AFEB-698C93BFD9D3</gtr:id><gtr:title>In Peruvian shantytowns, the financial impact of TB-related and catastrophic costs has not changed over the past decade, despite changes in TB rates</gtr:title><gtr:parentPublicationTitle>International Journal of TB &amp; Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3209658E-6892-4E87-AADD-B5F76BF4443B"><gtr:id>3209658E-6892-4E87-AADD-B5F76BF4443B</gtr:id><gtr:title>Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4109142e4d9b1be9cab6b8368fc6cd37"><gtr:id>4109142e4d9b1be9cab6b8368fc6cd37</gtr:id><gtr:otherNames>Dudley MZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31072242-A9D1-4C9D-89B9-1E25058341EB"><gtr:id>31072242-A9D1-4C9D-89B9-1E25058341EB</gtr:id><gtr:title>Innovative community-based partnerships to reach the unreached Invited presentation at the annual conference of the Union Against TB</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d454b7737d1cc0bdf662e10602d5e48"><gtr:id>7d454b7737d1cc0bdf662e10602d5e48</gtr:id><gtr:otherNames>Marco A Tovar</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/998A6AC1-4FD0-4180-AD56-9E16E287D163"><gtr:id>998A6AC1-4FD0-4180-AD56-9E16E287D163</gtr:id><gtr:title>Logistic, ethical, and political dimensions of stepped wedge trials: critical review and case studies.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b2210d3ac0b6a81a4e92d32a47cf7731"><gtr:id>b2210d3ac0b6a81a4e92d32a47cf7731</gtr:id><gtr:otherNames>Prost A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E56329DB-55D2-4B0A-81CA-C87E6DECD9B3"><gtr:id>E56329DB-55D2-4B0A-81CA-C87E6DECD9B3</gtr:id><gtr:title>Reduced sensitivity of auramine stained sputum smears in MDR-tuberculosis</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b53ed37bbf8c135c1b986d54d7b6c4c"><gtr:id>7b53ed37bbf8c135c1b986d54d7b6c4c</gtr:id><gtr:otherNames>Datta S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01C282DA-15E2-4090-B6C5-B83EBA460371"><gtr:id>01C282DA-15E2-4090-B6C5-B83EBA460371</gtr:id><gtr:title>The seasonality of tuberculosis, sunlight, vitamin D, and household crowding.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C725FAF7-5F62-4E10-9E09-5E4229CC4040"><gtr:id>C725FAF7-5F62-4E10-9E09-5E4229CC4040</gtr:id><gtr:title>Sputum microscopy with fluorescein diacetate predicts tuberculosis infectiousness.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b53ed37bbf8c135c1b986d54d7b6c4c"><gtr:id>7b53ed37bbf8c135c1b986d54d7b6c4c</gtr:id><gtr:otherNames>Datta S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5E3AD18-C6DB-4FB9-8FF4-9A401B66592D"><gtr:id>A5E3AD18-C6DB-4FB9-8FF4-9A401B66592D</gtr:id><gtr:title>Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.</gtr:title><gtr:parentPublicationTitle>BioMed research international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40c627230d2f25213a92394184bcc95e"><gtr:id>40c627230d2f25213a92394184bcc95e</gtr:id><gtr:otherNames>van Halsema CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8E314A6-65B6-43F7-8860-14D357DDBBD5"><gtr:id>E8E314A6-65B6-43F7-8860-14D357DDBBD5</gtr:id><gtr:title>The economic effects of supporting tuberculosis-affected households in Peru.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A0B36121-F2A2-4BC5-8F63-4BC1D2AB70C7"><gtr:id>A0B36121-F2A2-4BC5-8F63-4BC1D2AB70C7</gtr:id><gtr:title>Multiple behaviour change intervention for diarrhoea control in Lusaka, Zambia: a cluster randomised trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b30748b86dd559bc252c9f6ca35203b"><gtr:id>2b30748b86dd559bc252c9f6ca35203b</gtr:id><gtr:otherNames>Greenland K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F27F4A54-B732-4633-9C41-16613EA10D6B"><gtr:id>F27F4A54-B732-4633-9C41-16613EA10D6B</gtr:id><gtr:title>Health, healthcare access, and use of traditional versus modern medicine in remote Peruvian Amazon communities: a descriptive study of knowledge, attitudes, and practices.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/58dc4d9548f30b88540cc826b48a293e"><gtr:id>58dc4d9548f30b88540cc826b48a293e</gtr:id><gtr:otherNames>Williamson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D07A7D06-EDF0-42E0-AE6E-A94236C0EAE0"><gtr:id>D07A7D06-EDF0-42E0-AE6E-A94236C0EAE0</gtr:id><gtr:title>Tuberculosis-related knowledge is associated with patient outcomes in shantytown residents; results from a cohort study, Peru.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/46d8b995e6934a478425fdaca902a36e"><gtr:id>46d8b995e6934a478425fdaca902a36e</gtr:id><gtr:otherNames>Westerlund EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD35D1F5-D8A8-4534-A3FA-6A938A3204E0"><gtr:id>AD35D1F5-D8A8-4534-A3FA-6A938A3204E0</gtr:id><gtr:title>Five questions to consider before conducting a stepped wedge trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/83c90920ebb2c122fb1355f3d53131cb"><gtr:id>83c90920ebb2c122fb1355f3d53131cb</gtr:id><gtr:otherNames>Hargreaves JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A50E2171-A4DC-4E81-BAE3-212CB7730F7A"><gtr:id>A50E2171-A4DC-4E81-BAE3-212CB7730F7A</gtr:id><gtr:title>Poverty predisposes patients to intermittent adherence to TB treatment International Journal of TB &amp;amp; Lung Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/768abae6d5acd7ae09ac9673138a487f"><gtr:id>768abae6d5acd7ae09ac9673138a487f</gtr:id><gtr:otherNames>Marco A. Tovar</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C0D6C59-E6A3-492E-9B17-22563370F55D"><gtr:id>0C0D6C59-E6A3-492E-9B17-22563370F55D</gtr:id><gtr:title>Factors associated with HIV-testing and acceptance of an offer of home-based testing by men in rural Zambia.</gtr:title><gtr:parentPublicationTitle>AIDS and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a87d5ad4e857a4832c1115e3cf423da8"><gtr:id>a87d5ad4e857a4832c1115e3cf423da8</gtr:id><gtr:otherNames>Hensen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1090-7165</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/35DC172A-574C-4F3C-A510-919AFB253FBE"><gtr:id>35DC172A-574C-4F3C-A510-919AFB253FBE</gtr:id><gtr:title>Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/88db9a27d3e8458fb03da881b599a7ad"><gtr:id>88db9a27d3e8458fb03da881b599a7ad</gtr:id><gtr:otherNames>Velen K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F5DC788E-4A56-4510-8FA4-2EBEDC7E8717"><gtr:id>F5DC788E-4A56-4510-8FA4-2EBEDC7E8717</gtr:id><gtr:title>Predicting mycobacterial load from the time of positive culture using MODS (microscopic- observation drug- susceptibility assay)</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f6ed1dede1753e32234f2e21ab61cbb"><gtr:id>7f6ed1dede1753e32234f2e21ab61cbb</gtr:id><gtr:otherNames>ES Ramos</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/56E433F9-2A35-4EEA-B6D0-54B5810ADE4A"><gtr:id>56E433F9-2A35-4EEA-B6D0-54B5810ADE4A</gtr:id><gtr:title>Comparison of the MDR/XDRTB Colour Test, Xpert MTB/Rif and MODS assays to diagnose rifampicin resistant TB</gtr:title><gtr:parentPublicationTitle>International Journal of TB &amp; Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b493360b5e6e1ef9bb2a3c14b14d42b3"><gtr:id>b493360b5e6e1ef9bb2a3c14b14d42b3</gtr:id><gtr:otherNames>Tovar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52DC4CD7-BC22-4400-9431-B767B751F3C9"><gtr:id>52DC4CD7-BC22-4400-9431-B767B751F3C9</gtr:id><gtr:title>Systematic review of strategies to increase men's HIV-testing in sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a87d5ad4e857a4832c1115e3cf423da8"><gtr:id>a87d5ad4e857a4832c1115e3cf423da8</gtr:id><gtr:otherNames>Hensen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/26D5E102-9BFF-49A3-88B0-9938359B8136"><gtr:id>26D5E102-9BFF-49A3-88B0-9938359B8136</gtr:id><gtr:title>Contact Investigation: A Priority for Tuberculosis Control Programs.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d2dfb265ac0c43b1f56888a4f179a4a"><gtr:id>9d2dfb265ac0c43b1f56888a4f179a4a</gtr:id><gtr:otherNames>Saunders MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8F98BE04-8CAE-4E38-9A13-C0198BD28BA8"><gtr:id>8F98BE04-8CAE-4E38-9A13-C0198BD28BA8</gtr:id><gtr:title>Results of a double-blind randomized placebo controlled trial evaluating micronutrient supplementation for preventing TB disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/724489504998fa96747397d35c8f1c08"><gtr:id>724489504998fa96747397d35c8f1c08</gtr:id><gtr:otherNames>Tovar MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA692A4F-3B48-4C8F-91F8-258D1558CE71"><gtr:id>FA692A4F-3B48-4C8F-91F8-258D1558CE71</gtr:id><gtr:title>Targeting TB preventive therapy to those at high risk: derivation and validation of a risk score for predicting TB disease International Journal of TB &amp;amp; Lung Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d2dfb265ac0c43b1f56888a4f179a4a"><gtr:id>9d2dfb265ac0c43b1f56888a4f179a4a</gtr:id><gtr:otherNames>Saunders MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B146238C-8A52-4CA2-9392-C283E8C1DF51"><gtr:id>B146238C-8A52-4CA2-9392-C283E8C1DF51</gtr:id><gtr:title>Body mass index and TB incidence: A consistent dose-response relationship among adult household contacts International Journal of TB &amp;amp; Lung Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d2dfb265ac0c43b1f56888a4f179a4a"><gtr:id>9d2dfb265ac0c43b1f56888a4f179a4a</gtr:id><gtr:otherNames>Saunders MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FFDC0A96-41F0-493D-9A09-3A304F1FB905"><gtr:id>FFDC0A96-41F0-493D-9A09-3A304F1FB905</gtr:id><gtr:title>A new operational definition of intermittent-adherence to tuberculosis treatment is associated with high recurrence risk</gtr:title><gtr:parentPublicationTitle>International Journal of TB &amp; Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/724489504998fa96747397d35c8f1c08"><gtr:id>724489504998fa96747397d35c8f1c08</gtr:id><gtr:otherNames>Tovar MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B9AAFA36-B0AC-4140-8D10-6978E9C69510"><gtr:id>B9AAFA36-B0AC-4140-8D10-6978E9C69510</gtr:id><gtr:title>Financial interventions and modulation of malnutrition/food security in the context of tuberculosis</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9acb910bef1edf9a3044e12218c7b980"><gtr:id>9acb910bef1edf9a3044e12218c7b980</gtr:id><gtr:otherNames>K Zevallos</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5049A481-6286-47C1-A828-6B55AB9D0505"><gtr:id>5049A481-6286-47C1-A828-6B55AB9D0505</gtr:id><gtr:title>Universalization of rapid MDR-TB testing is associated with more rapid initiation of optimal patient therapy</gtr:title><gtr:parentPublicationTitle>Int J Tuberc Lung Dis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b493360b5e6e1ef9bb2a3c14b14d42b3"><gtr:id>b493360b5e6e1ef9bb2a3c14b14d42b3</gtr:id><gtr:otherNames>Tovar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B63CEFE8-E57F-4E0F-A143-84369D1BC872"><gtr:id>B63CEFE8-E57F-4E0F-A143-84369D1BC872</gtr:id><gtr:title>Preventing catastrophic costs: Opportunities and barriers for reducing household TB-related costs International Journal of TB &amp;amp; Lung Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea6ad72ff8bcb42f8c4c4cc75bf8bfe4"><gtr:id>ea6ad72ff8bcb42f8c4c4cc75bf8bfe4</gtr:id><gtr:otherNames>Williams SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C6770986-49D7-42A6-836F-4E76C1BDDDCE"><gtr:id>C6770986-49D7-42A6-836F-4E76C1BDDDCE</gtr:id><gtr:title>In TB patients from Peruvian shantytowns, catastrophic costs explain as many adverse TB outcomes as MDR TB</gtr:title><gtr:parentPublicationTitle>Journal of Infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66CC0D21-B671-44F8-8D3E-12D936D07112"><gtr:id>66CC0D21-B671-44F8-8D3E-12D936D07112</gtr:id><gtr:title>Effects of ascent to high altitude on human antimycobacterial immunity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ff05d5901fd9fa0b60d797eeb0cc3d13"><gtr:id>ff05d5901fd9fa0b60d797eeb0cc3d13</gtr:id><gtr:otherNames>Eisen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/915F564F-9B0E-4CE2-8B5F-0F092A39B551"><gtr:id>915F564F-9B0E-4CE2-8B5F-0F092A39B551</gtr:id><gtr:title>The Importance of Household versus Community Tuberculosis Transmission in Peruvian Shantytowns</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c1310bd9a2d9a307d346443f0177c09"><gtr:id>2c1310bd9a2d9a307d346443f0177c09</gtr:id><gtr:otherNames>Martinez L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9CB44072-DE86-412D-9FE3-4B9DC2A038AA"><gtr:id>9CB44072-DE86-412D-9FE3-4B9DC2A038AA</gtr:id><gtr:title>Seizures, cysticercosis and rural-to-urban migration: the PERU MIGRANT study.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd90e2ab7a06454dc8597fd4cd754102"><gtr:id>fd90e2ab7a06454dc8597fd4cd754102</gtr:id><gtr:otherNames>Gonzales I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A8464024-CFA1-436D-BD2A-0BB9CE257CEE"><gtr:id>A8464024-CFA1-436D-BD2A-0BB9CE257CEE</gtr:id><gtr:title>Socioeconomic support to improve initiation of tuberculosis preventive therapy and increase tuberculosis treatment success in Peru: a household-randomised, controlled evaluation</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/24D2C4E9-8FE2-430A-ADC9-14CB8418287F"><gtr:id>24D2C4E9-8FE2-430A-ADC9-14CB8418287F</gtr:id><gtr:title>Health Seeking Behaviours Associated with Tuberculosis Diagnostic Delay in Lima, Peru</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3714ea3e4b182395366e1f39618afa7a"><gtr:id>3714ea3e4b182395366e1f39618afa7a</gtr:id><gtr:otherNames>Bonadonna LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB5A6933-2BDB-48A3-A7A6-B090AF09B310"><gtr:id>EB5A6933-2BDB-48A3-A7A6-B090AF09B310</gtr:id><gtr:title>Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8bd37be9e9f636919cc372cca3fee13f"><gtr:id>8bd37be9e9f636919cc372cca3fee13f</gtr:id><gtr:otherNames>Jha S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F06F7FA6-F203-4568-A02E-A31D1747F415"><gtr:id>F06F7FA6-F203-4568-A02E-A31D1747F415</gtr:id><gtr:title>Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/479a684ce45ca3605e84ac4ef3578925"><gtr:id>479a684ce45ca3605e84ac4ef3578925</gtr:id><gtr:otherNames>Vynnycky E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0A756929-2F94-442B-A02A-0B8BCD3641A1"><gtr:id>0A756929-2F94-442B-A02A-0B8BCD3641A1</gtr:id><gtr:title>TB-related dissaving was common and correlated with incurring catastrophic costs in TB-affected households in Peruvian shantytowns</gtr:title><gtr:parentPublicationTitle>International Journal of TB &amp; Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44F759E4-EFDE-46BC-A1B5-8A8B5F987D83"><gtr:id>44F759E4-EFDE-46BC-A1B5-8A8B5F987D83</gtr:id><gtr:title>Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/799CC864-F4D5-4920-9A18-0BE05090CB4C"><gtr:id>799CC864-F4D5-4920-9A18-0BE05090CB4C</gtr:id><gtr:title>Risk factors for false-negative Mycobacterium tuberculosis cultures and their association with treatment outcomes in Peru: a retrospective cohort analysis</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e3bbe661fbdcf35aa02733c8f1b06400"><gtr:id>e3bbe661fbdcf35aa02733c8f1b06400</gtr:id><gtr:otherNames>Wendell j</gtr:otherNames></gtr:author></gtr:authors></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5BBAA45C-8584-4578-96CB-2892523BAA62"><gtr:id>5BBAA45C-8584-4578-96CB-2892523BAA62</gtr:id><gtr:title>Int J Tuberc Lung Dis</gtr:title><gtr:parentPublicationTitle>Poverty predisposes patients to intermittent adherence to TB treatment.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/724489504998fa96747397d35c8f1c08"><gtr:id>724489504998fa96747397d35c8f1c08</gtr:id><gtr:otherNames>Tovar MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A58D960C-4337-4CE6-8CBB-C1AB2DEA06FF"><gtr:id>A58D960C-4337-4CE6-8CBB-C1AB2DEA06FF</gtr:id><gtr:title>Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/649892b95b1cbc700f094f1738bbacc2"><gtr:id>649892b95b1cbc700f094f1738bbacc2</gtr:id><gtr:otherNames>Sathyamoorthy T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A846F391-DE1C-4CEC-B256-E310242D7AA6"><gtr:id>A846F391-DE1C-4CEC-B256-E310242D7AA6</gtr:id><gtr:title>Household HIV Testing Uptake among Contacts of TB Patients in South Africa.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/88db9a27d3e8458fb03da881b599a7ad"><gtr:id>88db9a27d3e8458fb03da881b599a7ad</gtr:id><gtr:otherNames>Velen K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F2CD2B00-7F0C-4452-BCE4-F9BE5386F642"><gtr:id>F2CD2B00-7F0C-4452-BCE4-F9BE5386F642</gtr:id><gtr:title>Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c8b76b1b7a1aa911fc1266c31c006562"><gtr:id>c8b76b1b7a1aa911fc1266c31c006562</gtr:id><gtr:otherNames>Beard E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/501CC814-D0F4-4343-B534-8683FF986098"><gtr:id>501CC814-D0F4-4343-B534-8683FF986098</gtr:id><gtr:title>Fighting poverty to prevent tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d2dfb265ac0c43b1f56888a4f179a4a"><gtr:id>9d2dfb265ac0c43b1f56888a4f179a4a</gtr:id><gtr:otherNames>Saunders MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2434A87E-2E63-402C-8A43-24C50005ADCB"><gtr:id>2434A87E-2E63-402C-8A43-24C50005ADCB</gtr:id><gtr:title>A trial of mass isoniazid preventive therapy for tuberculosis control.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db38a119d3b71b292e899341f9f9cc30"><gtr:id>db38a119d3b71b292e899341f9f9cc30</gtr:id><gtr:otherNames>Churchyard GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0CDD092C-43D5-4E18-BBBD-0155F0A8B281"><gtr:id>0CDD092C-43D5-4E18-BBBD-0155F0A8B281</gtr:id><gtr:title>Protocol for studying cough frequency in people with pulmonary tuberculosis.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0daffa9e9f091e40cc0ae962cc0d0768"><gtr:id>0daffa9e9f091e40cc0ae962cc0d0768</gtr:id><gtr:otherNames>Proa?o A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F6A16F06-7F88-48CC-8BC4-7BB6F09B30A3"><gtr:id>F6A16F06-7F88-48CC-8BC4-7BB6F09B30A3</gtr:id><gtr:title>Discriminating active from latent tuberculosis in patients presenting to community clinics.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/163c414a6665f2268f516fbd69f1ce2b"><gtr:id>163c414a6665f2268f516fbd69f1ce2b</gtr:id><gtr:otherNames>Sandhu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B664BC5E-1C61-43B8-AB63-8FD0E970043A"><gtr:id>B664BC5E-1C61-43B8-AB63-8FD0E970043A</gtr:id><gtr:title>Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa.</gtr:title><gtr:parentPublicationTitle>Infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a02416caad5f6c3c2e5a01b603997f1d"><gtr:id>a02416caad5f6c3c2e5a01b603997f1d</gtr:id><gtr:otherNames>Marais E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-8126</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF39D42A-F42E-4C0E-BB7F-7F4ED382856A"><gtr:id>AF39D42A-F42E-4C0E-BB7F-7F4ED382856A</gtr:id><gtr:title>Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0daffa9e9f091e40cc0ae962cc0d0768"><gtr:id>0daffa9e9f091e40cc0ae962cc0d0768</gtr:id><gtr:otherNames>Proa?o A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06FDE691-B790-41DC-A801-120C82D0AEFB"><gtr:id>06FDE691-B790-41DC-A801-120C82D0AEFB</gtr:id><gtr:title>Beyond pills and tests: addressing the social determinants of tuberculosis.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/916E473D-7236-4488-87AD-D76125D9B2C8"><gtr:id>916E473D-7236-4488-87AD-D76125D9B2C8</gtr:id><gtr:title>A meta-analysis comparing different sputum collection methods</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b8c7451f865f69acdfbc50d57d2e74ce"><gtr:id>b8c7451f865f69acdfbc50d57d2e74ce</gtr:id><gtr:otherNames>Sumona Datta</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C596260D-D439-4DDD-9AF7-C208E945B41C"><gtr:id>C596260D-D439-4DDD-9AF7-C208E945B41C</gtr:id><gtr:title>Undiagnosed tuberculosis cases among previously TB-affected families: results of a prevalence survey in Peru</gtr:title><gtr:parentPublicationTitle>International Journal of TB &amp; Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/724489504998fa96747397d35c8f1c08"><gtr:id>724489504998fa96747397d35c8f1c08</gtr:id><gtr:otherNames>Tovar MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01D723BD-3711-4ECD-8C71-12ACE5409F48"><gtr:id>01D723BD-3711-4ECD-8C71-12ACE5409F48</gtr:id><gtr:title>Clinical evaluation of tuberculosis viability microscopy for assessing treatment response.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b53ed37bbf8c135c1b986d54d7b6c4c"><gtr:id>7b53ed37bbf8c135c1b986d54d7b6c4c</gtr:id><gtr:otherNames>Datta S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B6A2A22-BC05-436D-B428-5D7FBA44A8ED"><gtr:id>7B6A2A22-BC05-436D-B428-5D7FBA44A8ED</gtr:id><gtr:title>Socioeconomic Determinants of Antibiotic Consumption in the State of S&amp;atilde;o Paulo, Brazil: The Effect of Restricting Over-The-Counter Sales.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad22819bce691d818d7da3ab3ae1a60a"><gtr:id>ad22819bce691d818d7da3ab3ae1a60a</gtr:id><gtr:otherNames>Kliemann BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63BE556A-834F-4F66-A824-AE250C5E42B9"><gtr:id>63BE556A-834F-4F66-A824-AE250C5E42B9</gtr:id><gtr:title>The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d7f700e17d21d7f5e3b2f76f15c0374"><gtr:id>3d7f700e17d21d7f5e3b2f76f15c0374</gtr:id><gtr:otherNames>Hermans SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF826558-495F-49C5-B9A3-1CCA23BE949E"><gtr:id>FF826558-495F-49C5-B9A3-1CCA23BE949E</gtr:id><gtr:title>Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1af5840e7bd12264ce3141ce9d41bd11"><gtr:id>1af5840e7bd12264ce3141ce9d41bd11</gtr:id><gtr:otherNames>Copas AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0799C447-19C4-4E5B-A0FA-B7CD479BCDC2"><gtr:id>0799C447-19C4-4E5B-A0FA-B7CD479BCDC2</gtr:id><gtr:title>The economic effects of supporting tuberculosis-affected households in Peru.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/27968E75-4C33-4451-B627-7AF182180445"><gtr:id>27968E75-4C33-4451-B627-7AF182180445</gtr:id><gtr:title>Can micronutrient supplementation prevent TB in vulnerable household contacts? A randomised controlled trial International Journal of TB &amp;amp; Lung Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d2dfb265ac0c43b1f56888a4f179a4a"><gtr:id>9d2dfb265ac0c43b1f56888a4f179a4a</gtr:id><gtr:otherNames>Saunders MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54978983-53C6-4F88-BE44-AFC60E2380A2"><gtr:id>54978983-53C6-4F88-BE44-AFC60E2380A2</gtr:id><gtr:title>Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a5f2416a6118048487516afa4cc0e29f"><gtr:id>a5f2416a6118048487516afa4cc0e29f</gtr:id><gtr:otherNames>Kirwan DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D29570E-E7A3-49BA-80D6-56BBC7DA5B4C"><gtr:id>1D29570E-E7A3-49BA-80D6-56BBC7DA5B4C</gtr:id><gtr:title>Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a7e72c965e384e199b5ba0fcdf45fa5a"><gtr:id>a7e72c965e384e199b5ba0fcdf45fa5a</gtr:id><gtr:otherNames>Boccia D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4293C5D1-8D03-4FA5-944D-4EE863F9A45C"><gtr:id>4293C5D1-8D03-4FA5-944D-4EE863F9A45C</gtr:id><gtr:title>Eligibility for isoniazid preventive therapy in South African gold mines.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/767e26e459f263f3a394b81f5455d1db"><gtr:id>767e26e459f263f3a394b81f5455d1db</gtr:id><gtr:otherNames>Lewis JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CC34AFAF-8546-4566-9643-DE8914F8D7F6"><gtr:id>CC34AFAF-8546-4566-9643-DE8914F8D7F6</gtr:id><gtr:title>Tuberculosis - who is at highest risk? Derivation and validation of a risk score for predicting tuberculosis disease in adult contacts of infectious tuberculosis patients.</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d2dfb265ac0c43b1f56888a4f179a4a"><gtr:id>9d2dfb265ac0c43b1f56888a4f179a4a</gtr:id><gtr:otherNames>Saunders MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8DB1136-31CA-4793-934C-C102FFB9E727"><gtr:id>B8DB1136-31CA-4793-934C-C102FFB9E727</gtr:id><gtr:title>Changes in tuberculin skin test positivity over 20 years in periurban shantytowns in Lima, Peru.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c1310bd9a2d9a307d346443f0177c09"><gtr:id>2c1310bd9a2d9a307d346443f0177c09</gtr:id><gtr:otherNames>Martinez L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7687A62F-1591-4F5E-AC53-EA0D535225EB"><gtr:id>7687A62F-1591-4F5E-AC53-EA0D535225EB</gtr:id><gtr:title>Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dbd842659f7a86b11bd7867e48ee5e2e"><gtr:id>dbd842659f7a86b11bd7867e48ee5e2e</gtr:id><gtr:otherNames>Dorman SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3CC14675-1C62-4769-8190-A064F1509792"><gtr:id>3CC14675-1C62-4769-8190-A064F1509792</gtr:id><gtr:title>Performance of a Novel Algorithm Using Automated Digital Microscopy for Diagnosing Tuberculosis.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa33c90bd05fb1222e7ce63da75369f9"><gtr:id>aa33c90bd05fb1222e7ce63da75369f9</gtr:id><gtr:otherNames>Ismail NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E65D2D9-3ABE-4989-93E6-3A0FFE22D7A3"><gtr:id>0E65D2D9-3ABE-4989-93E6-3A0FFE22D7A3</gtr:id><gtr:title>Micronutrient supplementation augments anti-mycobacterial immune responses in TST reactive household contacts International Journal of TB &amp;amp; Lung Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d2dfb265ac0c43b1f56888a4f179a4a"><gtr:id>9d2dfb265ac0c43b1f56888a4f179a4a</gtr:id><gtr:otherNames>Saunders MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8CF0AFAC-8DEC-4231-9D88-0817A79601FC"><gtr:id>8CF0AFAC-8DEC-4231-9D88-0817A79601FC</gtr:id><gtr:title>Frequency of HIV-testing and factors associated with multiple lifetime HIV-testing among a rural population of Zambian men.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a87d5ad4e857a4832c1115e3cf423da8"><gtr:id>a87d5ad4e857a4832c1115e3cf423da8</gtr:id><gtr:otherNames>Hensen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D0FB2AE1-3AC1-4F30-9543-B55974EC0421"><gtr:id>D0FB2AE1-3AC1-4F30-9543-B55974EC0421</gtr:id><gtr:title>Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42f7c7c6107a6cd7198876022cb295cf"><gtr:id>42f7c7c6107a6cd7198876022cb295cf</gtr:id><gtr:otherNames>Liu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D634F4DC-44B0-4E20-97DB-2004AB141B80"><gtr:id>D634F4DC-44B0-4E20-97DB-2004AB141B80</gtr:id><gtr:title>Auramine staining and fluorescent microscopy for TB diagnosis: a controlled comparison of sputum smear microscopy protocols</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b53ed37bbf8c135c1b986d54d7b6c4c"><gtr:id>7b53ed37bbf8c135c1b986d54d7b6c4c</gtr:id><gtr:otherNames>Datta S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4E586E39-71DD-4CD1-B1B5-FFDC27086002"><gtr:id>4E586E39-71DD-4CD1-B1B5-FFDC27086002</gtr:id><gtr:title>Feedback from TB-affected households' receiving a socioeconomic intervention in Peruvian shantytowns: an acceptability assessment from the CRESIPT pilot study International Journal of TB &amp;amp; Lung Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22B7B137-DBBC-4ABF-B780-214BF56EEC85"><gtr:id>22B7B137-DBBC-4ABF-B780-214BF56EEC85</gtr:id><gtr:title>The role of sputum TB quantitative viability microscopy to predict patient infectiousness</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b53ed37bbf8c135c1b986d54d7b6c4c"><gtr:id>7b53ed37bbf8c135c1b986d54d7b6c4c</gtr:id><gtr:otherNames>Datta S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A13DFADB-4EC6-41D4-A0B5-77AABA62D49C"><gtr:id>A13DFADB-4EC6-41D4-A0B5-77AABA62D49C</gtr:id><gtr:title>Tuberculosis-related knowledge is associated with patient outcomes in shantytown residents; results from a cohort study, Peru.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/46d8b995e6934a478425fdaca902a36e"><gtr:id>46d8b995e6934a478425fdaca902a36e</gtr:id><gtr:otherNames>Westerlund EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0B26012-F96A-4D21-873C-CED3EB2B8B99"><gtr:id>E0B26012-F96A-4D21-873C-CED3EB2B8B99</gtr:id><gtr:title>Households receiving a TB-specific social protection intervention in Peruvian shantytowns placed more importance on social than economic support</gtr:title><gtr:parentPublicationTitle>International Journal of TB &amp; Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E2676C3-0C7A-4C0C-8123-F612E4EC5CD1"><gtr:id>0E2676C3-0C7A-4C0C-8123-F612E4EC5CD1</gtr:id><gtr:title>Impact of Infection Control Measures to Control an Outbreak of Multidrug-Resistant Tuberculosis in a Human Immunodeficiency Virus Ward, Peru.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6249630eb25d5d3da3f196a8bc1966ee"><gtr:id>6249630eb25d5d3da3f196a8bc1966ee</gtr:id><gtr:otherNames>Ticona E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/34429B7B-AE35-43A4-9066-52AECDDD9808"><gtr:id>34429B7B-AE35-43A4-9066-52AECDDD9808</gtr:id><gtr:title>Clinical evaluation of tuberculosis viability microscopy for assessing treatment response.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b53ed37bbf8c135c1b986d54d7b6c4c"><gtr:id>7b53ed37bbf8c135c1b986d54d7b6c4c</gtr:id><gtr:otherNames>Datta S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01368600-0F09-4099-B5D6-8290F6152285"><gtr:id>01368600-0F09-4099-B5D6-8290F6152285</gtr:id><gtr:title>Standardization of a TaqMan-based real-time PCR for the detection of Mycobacterium tuberculosis-complex in human sputum.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/96a4d7d9844b58c81613bc01e49fc301"><gtr:id>96a4d7d9844b58c81613bc01e49fc301</gtr:id><gtr:otherNames>Barletta F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22B02031-E03D-4147-A071-1316C91E5685"><gtr:id>22B02031-E03D-4147-A071-1316C91E5685</gtr:id><gtr:title>Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad24357326ec53a8a8f6a94520c6163c"><gtr:id>ad24357326ec53a8a8f6a94520c6163c</gtr:id><gtr:otherNames>Nahid P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39EEB1D9-8C16-4DF1-AE18-218D09EB7ADB"><gtr:id>39EEB1D9-8C16-4DF1-AE18-218D09EB7ADB</gtr:id><gtr:title>The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed37de469b0f052b64034ec8f3a675d6"><gtr:id>ed37de469b0f052b64034ec8f3a675d6</gtr:id><gtr:otherNames>Toit K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/07415412-870E-4932-80B5-CBA4C962D0B0"><gtr:id>07415412-870E-4932-80B5-CBA4C962D0B0</gtr:id><gtr:title>Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7AA6806D-48B3-4E93-908B-A3A27382ACBD"><gtr:id>7AA6806D-48B3-4E93-908B-A3A27382ACBD</gtr:id><gtr:title>'We can work it out': understanding and preventing diagnostic treatment delays International Journal of TB &amp;amp; Lung Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33e807d919d549a8981e73d2dd3c503d"><gtr:id>33e807d919d549a8981e73d2dd3c503d</gtr:id><gtr:otherNames>Bonadonna L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/13937401-F160-48B9-BE1A-108F648E06B6"><gtr:id>13937401-F160-48B9-BE1A-108F648E06B6</gtr:id><gtr:title>Molecular epidemiology of Mycobacterium tuberculosis among South African gold miners.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3675bbf6983e1b39f8c567a4cc7aea65"><gtr:id>3675bbf6983e1b39f8c567a4cc7aea65</gtr:id><gtr:otherNames>Mathema B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/495B28C6-8EC3-443B-9AD5-BD891AE4C767"><gtr:id>495B28C6-8EC3-443B-9AD5-BD891AE4C767</gtr:id><gtr:title>Risk factors associated with undetected pulmonary TB in a prevalence survey, Callao, Per&amp;uacute;.</gtr:title><gtr:parentPublicationTitle>Int J Tuberc Lung Dis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/724489504998fa96747397d35c8f1c08"><gtr:id>724489504998fa96747397d35c8f1c08</gtr:id><gtr:otherNames>Tovar MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C57B830-17E3-4722-8B32-25876F12600F"><gtr:id>3C57B830-17E3-4722-8B32-25876F12600F</gtr:id><gtr:title>Effectiveness and safety of misoprostol distributed to antenatal women to prevent postpartum haemorrhage after child-births: a stepped-wedge cluster-randomized trial.</gtr:title><gtr:parentPublicationTitle>BMC pregnancy and childbirth</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0dd3aa6a958a991acf54f1094b4477f4"><gtr:id>0dd3aa6a958a991acf54f1094b4477f4</gtr:id><gtr:otherNames>Ononge S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2393</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/58D75D51-2F8C-4D90-8C68-A434A4C87BF1"><gtr:id>58D75D51-2F8C-4D90-8C68-A434A4C87BF1</gtr:id><gtr:title>Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a5f2416a6118048487516afa4cc0e29f"><gtr:id>a5f2416a6118048487516afa4cc0e29f</gtr:id><gtr:otherNames>Kirwan DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3ECE208E-0548-4665-8681-9D4A6DE39A1B"><gtr:id>3ECE208E-0548-4665-8681-9D4A6DE39A1B</gtr:id><gtr:title>An innovative approach for designing and implementing drug-resistant tuberculosis (DR-TB) treatment adherence interventions International Journal of TB &amp;amp; Lung Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d9c49765f673ef1f57701d268a1de61"><gtr:id>7d9c49765f673ef1f57701d268a1de61</gtr:id><gtr:otherNames>K Alegria-Flores</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ABDF7BFD-1DC8-40A7-8B96-32616C850090"><gtr:id>ABDF7BFD-1DC8-40A7-8B96-32616C850090</gtr:id><gtr:title>A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfb1f9ace181986adec3170bc9422b85"><gtr:id>cfb1f9ace181986adec3170bc9422b85</gtr:id><gtr:otherNames>Wingfield T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1234567x</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3CB351A6-312A-4664-80D9-023FF1073C9D"><gtr:id>3CB351A6-312A-4664-80D9-023FF1073C9D</gtr:id><gtr:title>Evaluating the effect of micronutrient supplementation on preventing tuberculosis disease among high-risk adult household contacts of infectious tuberculosis patients: a double-blind randomised controlled trial.</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d2dfb265ac0c43b1f56888a4f179a4a"><gtr:id>9d2dfb265ac0c43b1f56888a4f179a4a</gtr:id><gtr:otherNames>Saunders MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K007467/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5841ECCD-C9B1-4B8B-993F-ACC8E9585125</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.1  Primary preventions interventions to modify behaviours or promote well-being</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>